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Background  
Hypertensive disorders of pregnancy are major causes of severe morbidity, long-term disability, and death of 
both mothers and their babies. About 10 percent of the women experience increased blood pressure during 
pregnancy and less than 8 percent of pregnancies develop the complication, pre-eclampsia. Among the pre-
eclampsia patients, about 10 percent develop severe pre-eclampsia and eclampsia. Globally, about 10-20 
percent maternal deaths are associated with eclampsia1. The majority of deaths of mothers and their babies 
caused by severe pre-eclampsia and eclampsia (PE/E) are preventable through provision of timely and effective 
medical care.2 
By 2015, at the conclusion of the Millenium Development Goals, Bangladesh had achieved a reduction in 
maternal death from 550 maternal deaths per 100,000 live births in 1990, to 170 maternal deaths per 100,000 
live births in 2015 (UNICEF, WHO, Requejo, Victoa, & Bryce, 2015). Despite the progress, there are still between 
5,000 and 6,000 maternal deaths every year in Bangladesh, where 20 percent are the result of pre-eclampsia 
and eclampsia (PE/E) (NIPORT, MEASURE Evaluation, & icddr,b, 2012).  
To fully understand the key challenges, gaps, and interventions related to the prevention and treatment of PE/E 
at the national level, Ending Eclampsia conducted a systematic review of papers on PE/E in Bangladesh 
published between 2000 and 2015. 
WHAT IS PRE-ECLAMPSIA AND ECLAMPSIA? 
While the precise medical cause of eclampsia is unknown and definitions of the condition vary, some generally 
accepted signs and symptoms used to diagnose it in pregnant women. Pre-eclampsia occurs when a woman 
experiences a rapid elevation of blood pressure to > 140/90 mmHg (hypertension) and increased levels of 
protein in the urine (significant proteinuria >0.3g/day or >30mg/mmol of urinary creatinine in random sample) 
after 20 weeks gestation (Magee et al., 2015). If untreated, it can progress to eclampsia, a maternal disorder 
characterized by seizures and other complications like kidney or liver damage. Without proper and timely 
treatment, eclampsia can kill a woman and/or her fetus.  
Diagnosing pre-eclampsia and managing it before it progresses to severe pre-eclampsia or eclampsia is critical 
for improving maternal and newborn survival. Pre-eclampsia is manageable, and eclampsia can be prevented 
through routine screening of blood pressure and protein levels in urine during antenatal care (ANC) visits as well 
as using low dose aspirin and calcium prophylaxis to righ risk pregnant women. If a pregnant woman has high 
blood pressure, a provider can prescribe specific antihypertensive drugs that are safe for use during pregnancy. 
Providers can also prevent and control eclamptic convulsions with a loading dose of injectable magnesium 
sulphate (MgSO4) and, if at a primary health center (PHC), they should refer the patient to secondary facilities 
for follow-up further monitoring and management.  
  
                                                          
 
 
1 World Health Organization (WHO) Make Every Mother and Child Count. The World Health Report 2005, WHO Geneva. 
2 World Health Organization (WHO) recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011, WHO. Geneva. 
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FIGURE 1   Diagnosing pre-eclampsia and eclampsia 
 
Adapted from: Wagner, L.K. (2004) 
 
 
The World Health Organization (WHO) recommends three main evidence-based approaches to prevent maternal 
mortality from PE/E (The World Health Organization, 2011): 
1) Preventing the incidence of PE/E by screening all pregnant women for signs and symptoms during ANC 
check-ups. Preventative interventions include calcium supplementation during pregnancy, low-dose 
aspirin prophylaxis, and family planning methods to delay pregnancies. 
2) Detecting early signs of PE by measuring blood pressure and protein levels in the urine during ANC visits 
to monitor and manage pre-eclampsia. 
3) Managing severe PE by administering anti-convulsant therapy ― MgSO4 ― to prevent or stop seizures, 
followed by careful monitoring of the pregnant mother and her fetus and planning a time to deliver the 
baby. 
The WHO recommends use of MgSO4 as the standard method of preventing eclampsia in women with severe 
pre-eclampsia, and for treating eclampsia (The World Health Organization, 2011). Women treated with MgSO4 
have a 67 percent reduced, risk of recurrent seizures compared to women treated with other drugs such as 
diazepam and phenytoin (Euser & Cipolla, 2009). Despite its proven efficacy, this inexpensive drug is often 
underutilized for various reasons, including lack of awareness and continued use of outdated methods 
(diazepam and phenytoin), poor access to supplies, and a lack of sufficient trained personnel to administer 
MgSO4 (Yeager & Patel, 2012). 
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PRE-ECLAMPSIA AND ECLAMPSIA IN BANGLADESH 
Only 64 percent of pregnant women in Bangladesh aged 15-49 receive at least one ANC visit with a skilled health 
provider. (NIPORT et al., 2012). According to the Bangladesh Maternal Mortality and Health Care Survey 2010, 
PE/E is responsible for between 1,000 and 2,000 maternal deaths – 20 percent – making it the second leading 
direct cause of maternal mortality.  
The life-saving, magnesium sulphate has been on the national essential medicines list since 2008 at the latest, 
and national policy states that secondary and tertiary facilities can administer MgSO4, however, only 21 percent 
of secondary facilities and no primary facilities have it in stock (Ending Eclampsia Landscape Analysis, 2016)3.  
Facilities in Bangladesh are often constrained due to inadequate stocking of MgSO4 (Bergeson-Lockwood, 
Madsen, & Bernstein, 2010). The Directorate General of Family Planning (DGFP) and Directorate General of 
Health Services (DGHS) are both responsible for procuring magnesium sulphate, however they rarely coordinate 
and therefore supplies in stock may be very low or near their expiration dates (Bergeson-Lockwood et al., 2010). 
This systematic review of peer-reviewed literature published between 2000 and 2016 aims to identify 
interventions adopted to treat and manage PE/E throughout Bangladesh. It specifically looks at issues around 
the quality of care, gaps in the evidence, and barriers to accessing PE/E services. 
Methods 
This systematic literature review was conducted in three phases, in which published literature on PE/E in 
Bangladesh was collected, organized, and analyzed.    
IDENTIFYING ARTICLES FOR REVIEW 
Search of Databases 
The research team developed two sets of key terms related to PE/E that captured citations for peer-reviewed 
papers on detection, management, and prevention of PE/E (Figure 2). The first search captured results that do 
not mention PE/E explicitly, while the second search included the medical subject headings (MeSH) terms for 
PE/E and HELLP syndrome, a rare complication of PE/E that results in liver and kidney failure. These searches 
used a combination of terms linking various aspects of the diagnosis, treatment, and prevention of pre-
eclampsia, eclampsia, and other hypertensive disorders of pregnancy. Searches were limited to articles 
published from January 2000 to July 2016, and were run in PubMed and ScienceDirect.  
  
                                                          
 
 
3 http://www.endingeclampsia.org/resources/landscape-analysis-on-pre-eclampsia-and-eclampsia-in-
bangladesh-2/ 
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FIGURE 2   Diagram of search terms  
 
 
Any duplicate, non-English, or citations with irrelevant titles were excluded prior to Phase I. Titles and abstracts 
for the articles were imported into an excel spreadsheet for independent review. 
PHASE I: EXCLUSION CRITERIA 
During Phase I, two independent reviewers conducted title and abstract screenings to determine if the abstracts 
should be included or excluded in the next phase. Abstracts were excluded if they were:  
1) Not about Bangladesh,  
2) Not related to pregnancy; (for example: abstracts about male subjects and abstracts that discussed 
hypertension but not in pregnancy were excluded), 
3) Not related to PE/E or its associated risk factors, symptoms, or complications.  
The reviewers then reconciled their assessments, and in cases where it was unclear from the abstract of an 
article would provide relevant information, the reviewers consulted the full text article.   
After the conclusion of Phase I, and prior to beginning Phase II, the reviewers received expert recommendations, 
ran a basic “pre eclampsia and Bangladesh” search in an online database called ‘Bangladesh Journals Online’. 
PHASE II: INCLUSION AND EXCLUSION 
In the second phase, the same reviewers read the full texts of the remaining articles to determine their relevance 
and eliminated any papers that were not related to PE/E, did not focused enough on Bangladesh or did not 
provide any substantive data or observations specific to Bangladesh, and any papers for which a full text could 
not be acquired.  
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PHASE III: CATEGORIZATION 
Finally, the remaining articles were sorted into four types of papers — based on the main topic of each — that 
were found during the systematic review. 
1) Descriptive: Case reviews, project reports, literature reviews, etc. 
2) Potential risk factors for pre-eclampsia 
3) Other health outcomes associated with PE/E  
4) Intervention/hypothesis 
The goal was to identify articles that presented evidence on interventions that addressed the diagnosis, 
treatment, or prevention of PE/E.  
Results 
After removing duplicate citations and those unrelated to this review, the initial database searches identified 
315 abstracts, which were included in Phase I. Reviewers removed 257 articles that were deemed to not fulfill 
the inclusion requirements for Phase I.  
After the conclusion of Phase I and prior to beginning Phase II, the reviewers received 12 citations from experts 
in Bangladesh. Of these 12 citations, four were published prior to 2000, four had already been identified by this 
study’s search terms, one was not a peer-reviewed paper, and three were new, potentially relevant citations that 
were added to the review for Phase II. The reviewers also became aware of Bangladesh Journals Online, a 
database for papers published in peer-reviewed Bangladeshi journals, and ran the search terms to identify 
additional citations. The search found 119 new citations that had not been made available to any of the 
international databases used during the original search. The researchers felt it was of the utmost importance to 
acquire as many of these local papers as possible to better assess the existing information on PE/E in 
Bangladesh. Only 66 of the 119 citations identified were added to Phase II, 37 were not related to PE/E, 11 were 
not specific to Bangladesh, and five had been previously identified. 
During Phase II, 130 citations went to full text review, two were not available in full text, and 35 did not fulfill 
Phase II inclusion criteria (details in Annex V). A total of 93 articles were included in the systematic review and 
sorted into four categories: Descriptive, risk factors, other health outcomes, and interventions. 
  
6 
FIGURE 3   Flow diagram of systematic review methods and results 
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SUMMARY OF TOPICS FROM THE LITERATURE 
Descriptive papers 
Twenty of the literature review results only describe cross-sectional health outcomes, usually collected from 
hospital records and usually in an urban setting. Thirteen out of the twenty descriptive papers were collected in 
urban centers such as Dhaka, Sylhet, Mymensingh and Chittagong. Details from these papers included incidence 
rates, case fatality rates, cesarean section rates, and neonatal death rates. Incidence rates for eclampsia ranged 
from a low of 3.05 percent to a high of 9 percent (Akhtar, Ferdous, & Bhuiyan, 2011; Mosammat Rashida Begum, 
Begum, Quadir, Akhter, & Shamsuddin, 2004). Only two case fatality rates appeared in the descriptive papers, 
they showed 5 percent of 212 cases of eclampsia and 8.4 percent of 416 cases died as a result of eclampsia 
(Akhtar et al., 2011). Proportions of maternal deaths due to PE/E at study sites vary. Tasnim et al. found that 
severe PE/E was the primary obstetric cause of death (42.5 percent of 40) at the Institute of Child and Mother 
Health in Dhaka, while Ashraf et al. reported that eclampsia caused approximately 86 percent of 37 maternal 
deaths at Kushtia General Hospital (Ashraf, Mustanzid, & Khanom, 2007; Tasnim, Kabir, Rahman, Ahmed, & 
Chowdhury, 2006). Though most of the papers reported data from specific facilities, some looked at multiple 
locations in Bangladesh and presented a more representative picture of hypertensive disorders in pregnancy. 
Rahman et al. conducted hospital record reviews and interviews with clinic and field workers to identify deaths 
among women 10-50 years of age. In their study, they identified 8,562 maternal deaths, of which 82.8 percent 
(n=7,086) were due to obstetric causes and 34.3 percent of those obstetric deaths were from eclampsia (M. H. 
Rahman, Akhter, Chowdhury, Yusuf, & Rochat, 2002).  
Eclampsia occurs after 20 weeks gestation, and can occur before, during, or after delivery, but only two of the 
studies described the frequency or the timing of the onset. Afroj reported on 212 cases of eclampsia, and of 
those 50 percent occurred antepartum, 26.5 percent were intrapartum, and 23.5 percent were postpartum 
(Afroj, 2009). Another paper showed a similar trend and reported that out of 2,956 cases of eclampsia, 80 
percent occurred either ante- or intrapartum, while 20 percent were postpartum.   
Only one of the papers reported on the prevalence of postpartum hypertension. Fronczak et al. interviewed 1,506 
women who experienced delivery-related complications or postpartum morbidities, and found 11 percent 
experienced hypertension after 14 days and before 22 days postpartum (Fronczak, Antelman, Moran, Caulfield, 
& Baqui, 2005).  
Demonstrated and Potential Risk Factors 
Thirty-eight results focused primarily on issues around risk factor for pre-eclampsia, 32 of which reported data 
from urban areas of Bangladesh. Although the biological mechanism for developing pre-eclampsia or eclampsia 
remains unclear, many studies aimed to identify its risk factors because a stronger understanding of its causes 
would enhance health providers’ ability to detect and treat it. Some articles discussed birth spacing, maternal 
age, and a lack of quality antenatal care, elevated enzymes and amino acids or hormone levels (abnormal 
thyroid). In the reviewed journal articles, four themes emerged: socio-economic factors, micronutrient, mineral 
and trace element deficiencies, changes in clinical biomarkers, and patient’s medical history of obesity and 
autoimmune disorders like diabetes or pre-existing hypertension.  
Care seeking, maternal age and birth spacing 
Four studies examined socio-economic risk factors that included maternal age, birth spacing, and antenatal care. 
Chakraborty 2003 used a small sample size, but found that edema and the risk of eclamptic convulsions 
increased with a woman’s age (Chakraborty, Islam, Chowdhury, & Bari, 2003). Razzaque 2005 revealed that 
pre-eclampsia was higher among those women with pregnancy intervals shorter than six months and pregnancy 
intervals that were 75 months or more. The same study also found that the incidence of pre-eclampsia with 
proteinuria was lower among teenagers and high blood pressure, anemia and edema are more common among 
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older women (Razzaque et al., 2005). Aktar 2007 looked at age, parity, residence, economic status, number of 
antenatal care visits, referral authority, intervals between attacks and hospital admissions, and distance from 
facility. Each of these barriers were found to be risk factors for developing PE/E, and the authors recommended 
awareness of the importance of preventive care during antenatal visits, female education, and empowerment 
as solutions to reduce mortality from PE/E (Aktar & Sidiqua, 2007).   
Micronutrient, mineral and trace element deficiencies 
The role of micronutrient deficiencies in the development of pre-eclampsia was a major focus in the literature. 
Specifically, fifteen papers examined the connection between the disorder and low levels of calcium in pregnant 
women. Of the three studies that looked solely at calcium, all revealed that calcium intake was lower among 
women with pre-eclampsia than normotensive pregnancies (Jafrin et al., 2013; Jahan, Parvin, & Mafiz, 2011; A. 
Khatun et al., 2010). In addition to calcium, Akhtar 2013 incorporated zinc and magnesium into the study and 
found that deficiencies in these micronutrients also play a role in the pathogenesis of pre-eclampsia, and 
recommended routine screenings and surveillance of the three micronutrients during antenatal care. The same 
article recommended, as a prevention measure, that providers administer nutritional supplements when they 
discover deficiencies in pregnant women. Ullah 2013 found that low levels of Vitamin D was associated with a 
3-5 fold increase in risk of developing pre-eclampsia (Ullah, Koch, Tamanna, Rouf, & Shamsuddin, 2013).    
Several studies looked at the role of iron deficiency in pregnant women, with varying results and some studies 
found that pre-eclamptic women had lower levels of zinc, copper, manganese, ferritin, iron and magnesium 
(Jafrin et al., 2014; Sarwar, Ahmed, & Ullah, 2013). Others found high levels of iron and ferritin in mild and 
severe pre-eclampsia cases (Basher & Deb, 2006; Fatima et al., 2013; Yesmin et al., 2016). Researchers found 
that serum magnesium was low in mild pre-eclampsia, and even lower in severe pre-eclampsia (Jafrin et al., 
2014). Others found that low levels of it were common in women experiencing eclamptic fits (Akther & Rashid, 
2009). Similarly, another study found serum magnesium to be significantly lower in women with eclampsia than 
women with pre-eclampsia, and recommended its measurement to detect PE/E among high-risk groups. When 
detected, oral magnesium supplements could be given during pre-pregnancy or early pregnancy for prevention 
(Nahar, Yasmin, & Shamsuddin, 2010).  
Haque 2016 found eclampsia patients had lower selenium levels than normal pregnancies, and recommended 
further research on selenium supplementation (Haque et al., 2016). Khan 2014 examined the salinity in drinking 
water and found that tube-well water had the highest sodium levels. They determined that women who drink 
from water sources with higher salinity were found to have high blood pressure, and so salinity in drinking water 
was associated with increased risk of PE/E and gestational hypertension (A. E. Khan et al., 2014).  
Clinical biomarkers associated with PE/E  
Elevated levels of serum homocysteine were found in eclamptic women in two studies (Mahal et al., 2009, 
2010), and a third found that elevated homocysteine was associated with PE, with a slight association of 
increased homocysteine level and increased severity of PE. The same study recommended routine measurement 
of homocysteine and potential B-vitamin supplementation when necessary (Hoque, Bulbul, Mahal, Islam, & 
Ferdausi, 2008). Hosna et al found that serum uric acid was signficanlty higher among women with pre-
eclampsia (Hosna et al., 2008). 
The remaining studies examined the connection between hormones and PE/E. Begum 2014 found levels of 
serum beta-human chorionic gonadotropin – a hormone made by the placenta during pregnancy – were much 
higher in pre-eclampsia cases, and as the disorder progressed the levels of serum beta-human chorionic 
gonadotropin also increased (Z. Begum, Ara, Tanira, & Keya, 2014). Sultana 2013 found that increased serum 
C reactive protein is associated with pre-eclampsia, but whether it is the cause or effect remains unknown (S. 
Sultana, Dabee, Akter, & Akhter, 2013).  
Several studies researched the platelet counts of pre-eclamptic and eclamptic patients. One found that low 
platelet count is associated with pre-eclampsia and could be useful in its detection since platelet counts in 
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controls were between 51,000 and 198,000, compared to pre-eclampsia cases with platelet counts of 96,000 
and 144,000 (R. Sultana, Karim, Atia, Ferdousi, & Ahmed, 2012). Another discovered that eclampsia patients 
had platelet counts of 150,000, and patients with pre-eclampsia or gestational hypertension had platelet counts 
between 150,000 and 200,000 (Rahim, Nahar, & Khan, 2010).  Khatun 2000 found that six days after delivery, 
plasma neuropeptide Y concentration levels were four times higher in eclampsia cases and two times higher in 
pre-eclampsia cases, and Mondal 2016 found that the serum total of bilirubin and alanine aminotransferase 
(ALT) – an enzyme found in the liver and kidneys – were significantly higher in PE/E groups than among groups 
of women with normal pregnancies (S. Khatun et al., 2000; Mondal et al., 2016). 
The last two studies looked at trophoblastic hypoperfusion –reduced blood flow to the placenta--and found it is 
the earliest and most consistent change in pre-eclampsia, and as a result was believed to be an important cause 
of disease (Sufrin et al., 2016). Yoshimura 2003 found that the Glu289AspeNOS gene is not a good marker for 
increased risk of PE (Yoshimura, Chowdhury, Yoshimura, & Okamura, 2003).  
History of obesity and associated autoimmune disorders: diabetes, thyroid disorders, and hypertension 
Researchers also looked at pregnant women’s history of diabetes, hypertension, abnormal thyroid function and 
cholestorerol levels, to understand further what puts a woman at risk of developing the disorder. Akter 2013 
found that more women with overt hypothyroidism (23.8 percent) than women with sub-clinical hypothyroidism 
(3.4 percent) developed pre-eclampsia (Akter, Tarannum, & Kabir, 2013). However Khanam 2013 found that 
high levels of thyroid stimulating hormones could be a predictor of pre-eclampsia, but recommended more 
research with larger sample sizes (Khanam & Ilias, 2013). 
Two studies examined diabetes. One found that women with diabetes were more likely to experience caesarian 
section, preterm birth, and low birth weight due to pre-eclampsia (Jesmin et al., 2011), and the other found that 
pre-eclampsia was more prevalent among women with gestational diabetes mellitus, compared to pregnant 
women without it (Mannan, Rahman, Ara, & Afroz, 2012). 
A 2010 study found an association between an increase in triglycerides and an increase in LDL cholesterol and 
decrease in HDL cholesterol concentration in pre-eclampsia (N. A. F. Islam, Chowdhury, Kibria, & Akhter, 2010). 
Another study found that serum triglycerides correlate with the severity of pre-eclampsia, and should be 
measured during pregnancy to determine the risk of PE/E (Manna et al., 2015). 
Ferdous 2012 found that women with complicated births were more likely to suffer from hypertension, and that 
women older than 30 years and women with high body mass index (BMI) were more likely to be hypertensive 
(Ferdous et al., 2012). Similarly, Ferdausi 2013 found women with a high BMI were more likely than women with 
a low BMI to suffer from pre-eclampsia (Ferdausi, Khatun, Ma, Rahman, & Rahman, 2013). 
Other Health Outcomes Associated with PE/E 
Different heath consequences often follow, or are associated with, PE/E occurrence. The 22 papers categorized 
as relating to “other health outcomes” summarize research or hospital data that link negative maternal, fetal, 
newborn, and child health outcomes to hypertensive disorders in pregnancy. Of these 22 papers, 21 papers 
looked at health outcomes resulting from PE/E in urban settings, and only one paper examined outcomes in a 
rural setting.  
Maternal Health Outcomes 
According to the literature, other health outcomes directly affecting women who have experienced hypertensive 
disorders in pregnancy include increased rates of cesarean section, reduced organ function, ocular changes, 
and reduced placenta size and weight.  
Five papers reported an association with hypertensive disorders in pregnancy and increased rates of cesarean 
section. Two papers looked at women with hypertensive disorders in pregnancy, one found that 50.8 percent of 
63 women were delivered by cesarean section and the other study reported 10 percent of 50 eclamptic women 
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who were delivered by cesarean section (Tahmina, Shahid, Hosna, & Alam, 2014). The other three studies, 
investigated indications for cesarean section. One found that 14 percent of 100 randomly selected case notes 
of cesarean sections were due to pre-eclampsia (L. Saha & Chowdhury, 2011) and the other two analyzed 100 
cesarean sections and found consistent rates. Wazed et al. reported 24 percent and 20 percent of cesarean 
section were due to eclampsia and pre-eclampsia, respectively, and Saha & Khan found 45 percent of cesarean 
section were because of hypertensive disorders in pregnancy (M. Saha & Khan, 2011; Wazed, Jahan, & Tanira, 
2009). 
Reduced organ function and ocular changes also appeared in the literature as health outcomes associated with 
hypertensive disorders in pregnancy. Bhowmik found that liver impairment was reported to be more frequent 
among women with pre-eclamptic toxemia and eclampsia, compared to normal pregnancies (Bhowmik, 2013). 
The most frequently discussed organ impaired by PE/E was the kidneys. Four studies examined renal 
impairement (Khatun et al., 2003; Parna, Latif, Sultana, Ali & Chowdhury, 2013; Khan et al., 2011; Rahman et 
al., 2012). Khan et al. found a facility rate of renal impairment was 10 percent, compared to 30 percent among 
women with eclampsia  (F. Khan, Rahman, Alam, & Das, 2011). Rahman et al. observed all pregnancy-related 
acute renal failure patients, and found eclampsia caused 19 percent of cases (S. Rahman et al., 2012). HELLP 
syndrome , usually resulting in total and multi-organ failure, while rare, is a serious health outcome caused by 
eclampsia (Nessa, Polash, Islam, Anam, & Bhuiyan, 2013; Parna, Latif, Sultana, Ali, & Chowdhury, 2013).  
Pulmonary edema, postpartum hemorrhage, cardiovascular accident, obstetric shock, and multi-organ failure, 
and death also appeared as other serious health outcomes associated with PE/E (Parna, Latif, Sultana, Ali, & 
Chowdhury, 2013; Tahmina, Shahid, Hosna, & Alam, 2014). 
Only one paper reported on experiences of ocular changes, which included abnormal visual acuity, conjunctival 
changes, disk changes, vascular changes, and retinal changes. In this study, 44 percent of women with 
eclampsia reported experiencing ocular changes compared to 8 percent of control women who had normal 
pregnancies (Nahar et al., 2012). 
Finally, three studies examined placentas to determine what, if any, were the trends in weight or size of placentas 
from normotensive pregnancies and eclamptic pregnancies. All three found lower placental weight, volume, and 
diameter for eclamptic placentas than from normal placentas (S. Sultana et al., 2007). Sultana et al. also 
examined the number of cotyledeon and found that eclamptic placentas had fewer cotyledeon numbers, but 
were not significantly different in thickness from healthy placentas (S. Sultana et al., 2007).  
Fetal, Newborn and Child Health Outcomes 
The fetal, newborn, and child health outcomes discussed in the literature include stillbirth rate, perinatal 
mortality, birth weight, preterm birth, and intrauterine growth retardation. The studies that examined these types 
of outcomes consistently found that babies born to eclamptic women were more likely to be stillborn, preterm, 
have low birth weight, and were more likely to die intrapartum. Hussain et al. found that the chance of a poor 
fetal outcome increased as uric acid levels increased in the mother (Hussain et al., 2011). Alam & Akter reported 
that within an eclampsia unit, the perinatal death rate (including stillbirth and early neonatal death) was 290 
deaths per 1000 live births (out of 300 mothers with 311 babies) (Alam & Akhter, 2008).  
Interestingly, only one study considered the effect that PE/E might have on a child’s development beyond the 
neonatal period. Anwar et al. looked at 110 cases of children diagnosed with cerebral palsy and found that 29.1 
percent of mothers of children with cerebral palsy had suffered from PE/E during the pregnancy (Anwar et al., 
2006). 
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Interventions for improved prevention, detection and management of PE/E 
Only fourteen of the identified papers examined methods for improving prevention, detection, and management 
of PE/E. Of these 14 papers, 10 examined PE/E in urban settings, two were rural, and two papers were unclear 
(Appendix l). 
Prevention strategies 
Two of the three papers written about strategies to prevent PE/E are based on the same study, which was 
conducted in Bangladesh and Columbia between March 2001 and March 2003 (J A Herrera et al., 2005; Julian 
A Herrera et al., 2006). The objective of the study was to determine if dietary supplementation of calcium plus 
conjugated linoleic acid (calcium+CLA) had an effect on reducing incidence of “vascular endothelial dysfunction” 
in pregnant women at high risk of HDP. The study selected and screened 220 primigravid women 19-35 years 
old, and recruited those who were between 18-22 weeks gestation and who had family history of pre-eclampsia 
and showed a “diastolic notch in uterine or arcuate artery waveforms” on Doppler ultrasonograpic exam. Fifty 
women agreed to participate (three refused). These women were then randomized into an experimental 
treatment group and a control group. The calcium+CLA group received daily supplementation of 600mg of 
calcium plus 450 mg of CLA, while the control group received a placebo. This study found that calcium+CLA 
supplementation significantly reduced the incidence of HDP in the study group (8 percent) compared to the 
placebo group (42 percent). The second paper published on this study concluded that calcium+CLA 
supplementation could also decrease “intracellular concentration of ionized free calcium in peripheral blood 
lymphocytes” (Herrera et al., 2006). 
The other strategy for prevention that was present in the literature dealt with client preferences for receiving 
calcium supplementation. The study tested four methods of supplementation: conventional tablets, chewable 
tablets, unflavored powder, and flavored powder (Baxter et al., 2014). The conclusion is that women generally 
preferred conventional tablets. While the study did not look at the possibility of delivery mechanism of calcium 
supplementation affecting risk of pre-eclampsia, it may be interesting to consider the results of this study when 
introducing dietary supplements.  
Approaches to improve detection of PE/E 
There were two papers that discussed approaches to improving PE/E detection; one focused on the supply side 
of care and the other on demand.  
Islam et al. conducted pre- and post-assessments of community awareness relating to signs and symptoms of 
eclampsia. The intervention used village theaters to increase community knowledge on eclampsia(K. S. Islam et 
al., 2001). Thirty randomly selected audience members answered questions about eclampsia, who it affects, 
what the symptoms are for women with eclampsia. The pre-performance results showed that 13 percent (4 
people) knew of someone who had died of eclampsia. After the performance, the post-assessment of the same 
individuals showed an increase in knowledge on eclampsia since 17 (57 percent) remembered cases fitting the 
symptoms. 
Yousuf et al., looked at improving the supply side of medical care provision to improve detection of PE/E. Their 
study set out to determine if 12-hour urine collection were as effective at detecting changes in albumin excretion 
in a 24-hour urine collection (Yousuf, Hussain, & Begum, 2011). In order to do this, the researchers collected 
two, 12-hour urine samples. The first sample was collected from 8:00 AM to 8:00 PM, and the second 
immediately following from 8:00 PM to 8:00 AM. This allowed the researchers to analyze both samples 
separately first, and then combine them for the 24-hour sample. Ultimately, they did not find significant 
differences between any of the samples. 
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New mechanisms for management of PE/E  
The remaining nine papers identified in this review test hypotheses addressing mechanisms for managing PE/E. 
These studies investigate areas for improvement across a range of areas from community members choosing to 
seek emergency care, controlling hypertension in pregnancy, managing PE/E with MgSO4, and delivery 
strategies.  
In an effort to improve health seeking behavior for obstetric emergencies, Banu et al. conducted a quasi-
experimental study that compared two control districts with four intervention districts in Bangladesh (Banu, 
Akter, Begum, Choudhury, & Nasreen, 2014). All sites received BRAC’s4 core interventions, which include 
education, water and sanitation, microfinance assistance, essential health care, health and nutrition education, 
family planning, immunization, pregnancy care, and vitamin A supplementation. The intervention also received 
components of the BRAC Improving Maternal, Neonatal and Child Survival (IMNCS) project, which involved 
developing the competency of community health workers (CHWs) on BRAC maternity with referral services for 
obstetric emergencies as in the IMNCHS project. What they found was that 52 percent of women who 
experienced obstetric emergencies in control districts sought EmOC, compared to 90 percent in the intervention 
districts.  
One study tested two modes of delivery for antihypertensive drugs to women with high blood pressure. The 
comparative study involved two groups of women with eclampsia and hypertensive emergencies. The patients 
either received an IV bolus of 5mg hydralazine followed by 2mg at 15-minute intervals or the official protocol, 
which involves an IV drip of hydralazine of 10 drops per minute and is increased by five drops at 15 minute 
intervals (M R Begum, Quadir, Begum, Akhter, & Rahman, 2002). All patients had their BP measured every five 
minutes in the first hour and every fifteen minutes after that until their BP stabilized. Researchers found that 
both protocols were safe and effective to manage hyptertension in pregnancy. 
Shamsuddin et al. conducted a quasi-experimental interventional study that looked at the impact of 
administering the initial, loading dose of MgSO4 at a patient’s home rather than waiting until she arrived at a 
facility. The intervention involved working with field workers in the intervention communities to increase 
community awareness and identify patients. Field workers would communicate with “focal persons” nearby who 
would diagnose the disorder and administer a loading dose of MgSO4, and then refer the patient to the nearest 
facility. The non-intervention group had 132 patients with severe PE/E who arrived at the hospital to be treated 
for severe PE/E (Shamsuddin et al., 2005). In the intervention group, 133 women received an initial MgSO4 
injection at home before going to the hospital. The study found that the initial injection controlled convulsions in 
94 percent of the intervention group, compared to 74.2 percent of the non-intervention group. Furthermore, only 
three from the intervention group, compared to 14 deaths in the non-intervention group. Maternal complications 
and stillbirth rates were also lower in the intervention group than in the non-intervention group. This study 
showed that reducing the time between onset and the first injection could reduce negative health outcomes for 
the mother and her baby.  
  
                                                          
 
 
4 BRAC is a large, Bangladesh-based international non-governmental organziation that was established in 1972 
and works on issues related to economic development, education, public health and disaster relief. BRAC 
currently operates in Asia, Africa and the Caribbean.  
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Magnesium Sulphate 
Three papers focus on aspects of magnesium sulphate delivery. The global standard for MgSO4, the Pritchard 
Regime, involves administering 4g IV and 5g injection in each buttock, followed by 5g intramuscular injections 
(IM) in alternating buttocks every four hours. It is important to note that none of the four studies use global 
standards for MgSO4 administration, but rather use a lower dose, assumed effective for smaller women in 
Bangladesh.  
In one study, 65 patients with eclampsia were given a “Dhaka” low dose of MgSO4, which involved 5g IV and 3g 
IM in each buttock, followed by 2.5g maintenance doses every four hours in alternating buttocks (R. Begum, 
Begum, Johanson, Ali, & Akhter, 2001b). The researchers monitored each patient every thirty minutes during the 
first six hours and every hour thereafter. They monitored respiratory rate, knee jerk, urinary output, and serum 
magnesium levels in blood samples. There were eight stillbirths and three early newborn deaths. During the 
study, there were no maternal deaths and only one patient experienced recurrent convulsions. Ultimately, the 
researchers concluded that the low dose “Dhaka” regime effectively controls and prevents breakthrough 
convulsions without reaching toxic levels. 
A randomized trial conducted at Dhaka Medical College and Hospital randomized 401 eclamptic patients into 
two groups. One group (n=199) received the standard regime in Dhaka of 4g IV with 3g IM in each buttock 
followed by 2.5g IM in alternating buttocks every four hours (for 24 hours) and the other group was only given 
the initial loading dose of 4g IV and 3 IM in each buttock (Mosammat Rashida Begum et al., 2002). All patients 
were managed the same way and those with diastolic blood pressure >110mmHg were given hydralazine to 
manage the hypertension. The two groups of women were comparable in clinical history and symptoms. In the 
study, there was no statistically significant difference in recurrent convulsion rates between the study group 
(3.96%) and the controls (3.52%). Stillbirth rates and cesearean section rates were also comparable between 
the two groups indicating that the loading dose of MgSO4 alone is as effective as loading dose followed by 
maintenance doses to control and prevent convulsions due to eclampsia. 
Sultana et al. conducted a randomized study that tested the effectiveness and safety of an alternative low dose 
treatment of 8g MgSO4 heptahydrate via IV to the conventional treatment of 4g MgSO4 IV with 3g IM in each 
buttock. Out of 100 total participants, 48 received the 8g IV treatment and 52 “controls” received the 
conventional treatment. The researchers found no statistically significant difference in recurrence rates of 
convulsions between the two groups. The time it took to regain consciousness, blood pressure levels at 
admission and discharge, and rates of maternal complications or death were not statistically significant between 
the two groups. The study results imply that 8g MgSO4 heptahydrate can effectively control convulsions in 
eclamptic patients (Sultana, Begum, Begum, Akhter, 2010). 
Conservative management of severe PE/E could prolong pregnancy until 36 weeks gestation; however, maternal 
or fetal complications sometimes develop. Another study conducted at Dhaka Medical College and Hospital 
selected participants who had been admitted to the eclampsia unit (21 patients with pre-eclampsia and 30 
patients with eclampsia) prior to 36 weeks gestation (Mosammat Rashida Begum et al., 2002). Each patient 
was given the conventional treatment in Dhaka of 4g IV following by 3g IM in each buttock, followed by 2.5g IM 
in alternating buttocks every four hours for 24 hours. Conservative management also involves measuring 
patient’s blood pressure four times daily, checking fetal heart sounds two times a day, and monitoring fetal 
growth using an ultrasound every two weeks. Twelve of the patients were able to reach 36 weeks gestation 
following recruitment at 32 weeks (n=5), 33 weeks (n=3) and 34 weeks (n=4). Of the 16 patients who were <30 
weeks at recruitment, only one baby survived. Overall, intrauterine death occurred in 19 cases. Based on these 
results, the researchers concluded that, in selected cases, with close monitoring and supervision, after 30 weeks 
gestation, providers could attempt conservative management. Further controlled trials with larger sample size 
are necessary to determine the protocol. 
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Delivery Mechanism 
More recently, in a study of 100 eclamptic women who were at term and admitted at Dhaka Medical College and 
Hospital, half were delivered vaginally and the other half were delivered by cesearean section (S. Begum, Islam, 
& Jahan, 2013). Maternal, fetal, and neonatal outcomes were recorded and analyzed. The study found that the 
group that delivered vaginally were more likely to experience stillbirth and birth asphyxia (20 percent stillbirth 
and 60 percent birth asphyxia) compared to the cesearean section group (6 percent stillbirth and 23.4 percent 
birth asphyxia). In addition, 6 percent of women who delivered vaginally died, while there were no maternal 
deaths in the cesearean section group. The researchers concluded that women with eclampsia who delivered by 
cesearean section had better feto-maternal outcomes compared to women delivering vaginally.  
When performing cesearean section, there are two methods for administering anaesthesia: general anaesthesia 
and subarachnoid block. Basu et al, conducted a randomized comparison of women with eclampsia who required 
cesearean section delivery. Participants were randomized into two groups and received either general 
anaeshtesia or spinal anaesthesia. Researchers performed tests prior to, during, and after operation, and found 
that there was no significant difference in average highest blood pressure or Glasgow coma scores (24 hours 
after operation). The researchers conclude that spinal anaesthesia is as good a method as general anaesthesia 
for cesearean section deliveries for women with eclampsia (Basu, Begum, Karim, & Rahman, 2006). 
Discussion  
The main findings from this systematic review addressed several aspects of PE/E prevention, detection, and 
management in Bangladesh. The lack of awareness among pregnant women and their families about when to 
seek care when pregnancy-related complications arise was one finding. Variations in definitions of hypertensive 
disorders of pregnancy, dosing and timing of MgSO4 administration, and in clinical biomarkers also came out of 
the review. Reviewers also identified several gaps and limitations in the current available research and provided 
recommendations for future study on PE/E in Bangladesh.   
COMMUNITY AWARENESS AND KNOWLEDGE 
There are multiple socioeconomic barriers – financial, social, cultural, and transportation – that affect a woman’s 
ability to seek care and may ultimately result in death. In the literature, there was little information about the 
awareness and knowledge among community members. However, two studies focused on improving health-
seeking behavior and health outcomes by increasing community awareness. One intervention used village 
theater to improve community awareness and knowledge, and demonstrated that even in communities where 
PE/E is relatively common, many community members do not know about the condition or the signs and 
symptoms that should cause concern (K. S. Islam et al., 2001). In the study, the same interviewees responded 
to questions about eclampsia. After the educational village theatre performance, more respondents answered 
‘yes’ when asked if they were aware of anyone who experienced eclampsia, indicating that they did not know 
that the signs and symptoms they witnessed were actually signs of eclampsia.  
Another example of the importance of community awareness on health-seeking behavior comes from a quasi-
experimental study that implemented an intervention using community health workers (CHWs) to empower 
communities and provide ‘homestead health services’ (Banu et al., 2014). The comparison group received 
BRAC’s core interventions on education, water and sanitation, microfinance, etc. When comparing the health-
seeking behavior of the two groups, the researchers saw that among women who experienced obstetric 
emergencies in the intervention group, 90 percent sought emergency obstetric care, compared to 52 percent 
from the comparison group. This community-based intervention indicated that CHWs are effective at increasing 
community awareness of danger signs and symptoms in pregnancy, and can lead to more health-seeking 
behaviors among women experiencing obstetric emergencies. 
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Ultimately, if pregnant women and members of their community are not aware of the signs and symptoms of 
eclampsia, and are uninformed about the seriousness of hypertensive disorders in pregnancy, they are less likely 
to access health services. Based on these two studies, it appears that community awareness of danger signs 
and symptoms is low. Without an understanding of the risks that these conditions can have on a pregnant woman 
and her baby, community members are unlikely to promptly seek health services from trained personnel. 
Increasing awareness around issues related to pregnancy, specifically PE/E, can lead to improved health-seeking 
behavior and therefore better health outcomes. As women in these settings are often not the decision makers 
in a household, it is critical that these health messages penetrate to other members of the community, such as 
husbands and mothers-in-law with the hope that they will recognize dangerous symptoms and encourage 
pregnant women to access health services.  
TERMINOLOGY AND CLINICAL DEFINITIONS 
In the 94 full text articles included in this review, there were 12 different terms defined and used to discuss the 
spectrum of hypertensive disorders (Tables presenting the terms and the various clinical definition provided can 
be found in Appendix II). Two of these terms, “essential hypertension” and “hypertension” do not relate 
specifically to pregnancy, and are not markedly different from one another. The remaining 10 terms refered to 
degrees of hypertension in pregnancy and required different clinical findings for those diagnoses.  
Though one could logically conclude that “gestational hypertension” and “gestational proteinuric hypertension” 
likely refer to the same condition, the purpose here is to emphasize the overabundance of terms that can be 
used when discussing hypertensive disorders in pregnancy.  
Generally speaking, “toxemia” is an outdated term uncommonly used today to classify types of hypertensive 
disorders of pregnancy. Though several articles use the term “toxemia,” only two provide definitions. The first, 
Hassan et al., equates “pre-eclamptic toxaemia” with pre-eclampsia. The second, deliberately explains that 
“toxemia of pregnancy” has two types: Pre-eclampsia and eclampsia (Jahan et al., 2011). These two definitions 
are in stark contrast with each other and create a murky understanding of what exactly ‘toxemia’ means for a 
patient.  
Definitions for “pre-eclampsia” appear in fifteen articles, each setting its own standard clinical requirements for 
diagnosis. The majority require some form of high blood pressure. Though nine definitions state 140/90 mmHg 
as the blood pressure level for diagnosing pre-eclampsia, two of those definitions provide an alternate blood 
pressure measurment. Both Jesmin et al. and Khatun et al. state that a relative rise in baseline systolic blood 
pressure of 30 mmHg or more, or a relative rise in diastolic blood pressure of 15 mmHg or more would indicate 
possible pre-eclampsia (Jesmin et al., 2011; S. Khatun et al., 2000). Three authors remain vague when 
describing the blood pressure measurement and state merely that women with pre-eclampsia have high or 
elevated blood pressure or hypertension (Kishwara, Tanira, Omar, Wazed, & Ara, 2011; S. Rahman et al., 2012; 
Razzaque et al., 2005). Proteinuria after 20 weeks gestation are criteria that are usually included in the clinical 
definitions given. Only two of the fifteen omit proteinuria from their definitions (Fronczak et al., 2005; Jesmin et 
al., 2011). Five provide no restriction for the timing of onset of high blood pressure. As the table in Appendix II 
illustrates, minor nuances in clinical definitions exist, as well. Variations include specifications on how and when 
blood pressure is measured, or whether the woman experiences pain, headache, visual disturbances, or edema, 
among others.  
The abundance of existing terms that can describe the gradations of hypertensive disorders in pregnancy creates 
confusion for diagnosing and managing these life-threatening conditions. In low service utilization settings, 
providers may not encounter women with PE/E regularly and may not easily recall the nuanced distinctions 
between the terms along the spectrum of HDP. In order to enable these providers to diagnose and manage PE/E 
promptly, accurately, and thoroughly, clearer diagnosis guidelines that are in line with streamlined and precise 
definitions and management protocols are required. Creating specific and clear clinical definitions for these 
conditions is essential for providers to appropriately diagnose and manage PE/E symptoms. Given the wide range 
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of HDP-related definitions, reducing the number of terms and simplifing the definitions is a critical move to make 
if there are to be fewer women dying from the disorder. It is also necessary for moving beyond the idea that 
interventions vary significantly for each classification, when in fact, the monitoring and management methods 
do not vary between mild pre-eclampsia and eclampsia or severe pre-eclampsia and eclampsia.  
VARIATIONS IN ADMINISTRATION OF MGSO4  
Globally, there are two predominant regimens for administering MgSO4 to women with severe PE/E:  Pritchard 
and Zuspan. The Pritchard regimen is considered the ‘gold standard’ treatment method in low resource settings, 
and requires a 14g loading dose (4g delivered via IV followed by 5g IM in each buttock) followed by maintenance 
doses of 5g IM in alternate buttocks every four hours (Gordon et al., 2014). The Zuspan regimen requires more 
medical skills and equipment (involves setting up an infusion pump) to administer 4g IV and a drip maintenance 
dose of 1g/hour via IV (Gordon et al., 2014). Though there is evidence to support the effectiveness of both 
regimens, there is no evidence to support the idea that the doses they require are the lowest amount effective 
for controlling convulsions.  
In Bangladesh, it is interesting to note that of the five research studies that investigated the question of MgSO4 
dose, none of them used Pritchard or Zuspan as the standard of care for comparison. These studies show that 
there is already an accepted alternative, reduced regimen that appears to be effective in small Bangladeshi 
women.  
Three studies demonstrated that a lower ‘Dhaka’ dose of MgSO4 is able to control fits in eclamptic women reliably 
and safely. The modified dose is nearly identical across the three studies; one defines the reduced dose as 5g 
MgSO4 delivered intravenously with 3g administered IM followed by maintenance doses of 2.5g IM in alternating 
buttocks delivered every four hours (R. Begum, Begum, Johanson, Ali, & Akhter, 2001a). The other two studies 
use the same structure with an initial IV injection of 4g instead of 5g, however, only one requires the maintenance 
doses (R. Begum et al., 2001b). One research study compared the ‘Dhaka’ dose compared with the ‘Dhaka’ 
loading dose alone, and concluded that a loading dose alone is as effective as the loading dose followed by 
maintenance doses using the ‘Dhaka’ regimen (M R Begum, Begum, & Quadir, 2002). These three studies were 
conducted in the late 1990s at Dhaka Medical College and Hospital and support the conclusion that, for smaller 
Bangladeshi women, a reduced dose of MgSO4 is as safe and effective as the globally accepted standards.  
Another study investigated the question of dosage of MgSO4 using the ‘Dhaka’ regimen as the accepted standard 
of care and testingthe lower 8g dose of MgSO4 delivered intravenously (N. Sultana, Begum, Begum, & Akhter, 
2010). The results of the randomized case-control study indicated that 8g IV MgSO4 can effectively control 
convulsions in eclamptic patients. 
These research studies prompt queries around the evidence behind the currently held ‘standard’ regimens 
requiring large amounts of MgSO4 to be administered regularly to women. The effectiveness of these lower doses 
indicated a need for further inquiry into identifying the lowest effective dose. Anecdotally, the small size of 
Bangladeshi women is cited as the reason why lower doses are adequate, but this requires more research. What 
characteristics would require a woman to receive a larger dose? Should the dose be based on patients’ weight? 
Many important questions need answers in order to establish the most reliable, least intrusive strategy to prevent 
and manage convulsions.  
In addition to dosing variations, Shamsuddin et al. tested a strategy for earlier administration of MgSO4. The 
intervention aimed to prove that reducing the time to first injection would reduce negative health outcomes for 
mothers and babies, compared to patients who arrive at hospitals without receiving the loading dose. The 
intervention involved assessing women’s condition, diagnosing severe PE/E, and administering the loading dose 
in the home and referring patients for follow up care would lead to improved health outcomes for women and 
their babies. It also demonstrated that lower level providers can effectively diagnose and safely administer the 
loading dose outside of a facility.  
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VARIATIONS IN CLINICAL BIOMARKERS 
Many of the reviewed papers looked at risk factors for PE/E, and revealed that elevated hormones and enzymes, 
history of autoimmune disorders, ANC visits, maternal age, and birth spacing all increase a woman’s chances of 
developing PE/E. The most common risk factors discussed in the literature, however, were micronutrient 
deficiencies. These primarily included calcium and magnesium, but also iron, zinc, ferritin, and copper. Knowing 
that insufficient levels of these micronutrients put a woman at higher risk of becoming pre-eclamptic means that 
increasing her intake of calcium and magnesium should reduce that risk. However, the most effective, lowest-
cost, and least invasive mechanism for increasing her uptake remains unclear. Is it a multi-vitamin or a single-
nutrient supplement? And should it be in tablet or capsule form? How often? What other resources, such as 
clean water, are required for regular supplementation? Are there other ways that might work better? 
Since the literature shows that micronutrient deficiencies are a serious matter that need attention, what it does 
not discuss are the cutoff levels for clinical biomarkers (micronutrient deficiencies and elevated hormones), 
which were also found to be risk factors. The protocols for analyzing when a deficiency or elevated hormone 
exists needs to be clear, in not only published literature but also more accessible to the providers conducting 
ANC check-ups in health facilities.   
LIMITATIONS AND GAPS IN CURRENT RESEARCH 
There are several limitations to the evidence available. Few studies measured the utility and safety of task-
shifting to PHC level providers which can be a useful way to reduce delays in treatment. There was a lack of 
research relating to the postpartum period, despite the fact that eclampsia can still occur in women who have 
delivered. Also, due to wide variations in and inconsistent terminology there is an ambiguity associated with the 
spectrum of hypertensive disorders in pregnancy, which may reduce provider confidence in identifying and 
managing PE/E. The published research revealed some gaps for PE/E prevention, detection, and treatment in 
Bangladesh. The first is the lack of input from the providers at any tier of the health system who are working to 
reduce maternal and neonatal deaths from PE/E. Although vital to understanding the ins and outs of 
Bangladesh’s second biggest killer of pregnant women, the research focused only on the experiences of PE/E 
patients and their families. None of the research looked at the ways in which facility providers are hindered in 
their work to manage hypertensive disorders of pregnancy, and that is a powerful voice that needs to be heard 
if there are to be fewer deaths from PE/E. 
Another limitation was that the overwhelming majority of the literature focuses on urban settings, with very little 
speaking to the experience of rural women, their families, or providers at primary facilities. As urban women are 
most likely closer to health services, with fewer or lesser barriers in her way, the reviewers felt that because 
there is a lack of research focused on rural women, their unique needs and opportunities for accessing quality 
health services are unclear. 
Recommendations 
• Determine variables that impact efficacy of lower doses, including whether subsets of women require 
different dosages to effectively and safely control convulsions. Generate a clear, evidence-based 
dosing regimen that uses the lowest effective dose for women with PE/E. 
• Simplify terminology used to discuss HDP; eliminate overlapping terms that create ambiguity for 
diagnosis. Establish clear clinical guidelines to define each term for improved diagnosis of HDP. 
• Re-train providers, especially PHC providers to accurately diagnose PE/E. 
• Task shift initial doses of antihypertensive drugs and MgSO4 to PHC providers and strengthen referral 
mechanisms for follow up care. 
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• Work closely with community members and existing groups and networks to increase the layperson’s 
awareness of danger signs in pregnancy, and specifically the signs and symptoms of HDP. 
• There is a strong need for more research on the most effective, lowest-cost, and least invasive means 
of administering nutritional supplements that reduce micronutrient deficiencies.  
• To better detect micronutrient deficiencies and clinical biomarkers, more research that defines the 
protocol for analysis during antenatal check-ups.  
• More analysis of the experience of rural woman and their families is needed, as most of the literature 
focuses on urban settings in Bangladesh, primarily Dhaka City. 
• Monitor women up to one year after delivery gain provide stronger understanding of the incidence of 
post partum PE/E and other health outcomes related to PE/E.   
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Appendix I: Summary Table of Interventions  
Citation Study Design & Methods Main Findings and Conclusions 
Banu et al., (2014) January—February 2010: Quasi-experimental case-control study. 
4 intervention districts (Nilphamari, Rangpur, Gaibandha and Mymensingh) received intensive maternity care and 
the intervention focused on developing competency of CHWs, community empowerment, rendering homestead 
health services, and establishing referral linkages with government and non-government health facilities. 
2 control districts (Netrokona and Naogaon) received BRAC’s core interventions (education, water and sanitation, 
microfinance assistance, essential health care, health and nutrition education, family planning, immunization, 
pregnancy care and vitamin A supplementation) 
• 90% of obstetric emergencies in intervention group sought 
EmOC compared to 52% in control group 
• 7.4% of women in intervention group experienced eclampsia, 
and had a median time to decide to seek care of 65 minutes 
• 3.8% of comparison group experienced eclampsia and had a 
median time to decide to seek care of 47 minutes. 
Basu, et al. (2006) January—December 2001: Randomized comparison at Dhaka Medical College Hospital. 
60 women with eclampsia (convulsion, hypertension, proteinuria) requiring cesarean section were randomized into 
groups receiving either general anesthesia or spinal anesthesia. Cases of eclampsia were also managed with 
MgSO4 and Hydralazine was given to lower BP over 110 mmHg. 
Preoperative, perioperative and postoperative parameters and tests were assessed and data were analyzed. 
• There was no significant difference in average highest BP, 
Glasgow coma score 24 hours after operation, birth weight. 
• Potential advantages of spinal anesthesia are early induction 
to delivery and better Apgar score of the infant, which may 
make spinal anesthesia as good a choice for eclamptic CS 
deliveries as general anesthesia. 
Baxter et al., (2014) November 2012—March 2013: Discrete-choice experimental design. 
149 pregnant women aged 18-39 years and gestational age of 13-30 weeks were enrolled from Shimantik 
Maternity Centre, Khilgao, Dhaka. 132 participants (17 withdrew) were given four choices for calcium 
supplementation: conventional tablets, chewable tablets, unflavored powder and flavored powder, each providing 
a daily dose of 1500 mg Ca.  
During a 4 day “run-in period” each participant was able to sample each option before making her selection—this 
period lasted 21 days; she was able to choose any of the four options independent of her previous choice(s) (2 
withdrew after run-in). 
Semi-structured questionnaires were conducted with the remaining 130 participants following the run-in period 
and after the selection period to assess various aspect which may have affected preference/choice (including 
taste, mouth feel, aftertaste, odor, size, ease of use). 
• This study set out to assess the preference and acceptability 
of four different delivery vehicles for prenatal calcium 
supplementation. 
• After primary analysis, conventional tablets (62%) were most 
chosen followed by, chewable tablets (19%), flavored powder 
(12%), unflavored powder (5%), none (2%) 
• 93% of participants selected conventional tablets at least 
once during the selection period. 
• Conventional tablets were the most chosen vehicle for every 
day of the study. 
Begum, Akhter, 
Begum, Khatun, 
Quadir, & Choudhury, 
(2002)  
January 1998—October 2000: Dhaka Medical College and Hospital.  
21 patients with PE and 30 patients with E; all <36 weeks were admitted into the Eclampsia Unit for conservative 
management to prolong pregnancy until 36 weeks gestation or until maternal or fetal complications began to 
develop. They received 4g IV MgSO4 administered slowly, and 3g IM in each buttock followed by 2.5g IM in 
alternate buttocks every 4 hours for 24 hours. They were put on bed rest, given oral phenobarbitone and an 
antihypertensive (methyldopa, hydralazine, nifedipine). All patients underwent 24-hour urine collection for 
measurement of urinary total protein. Serum urea, creatinine, uric acid platelet count, SGOT and SGPT were 
measured for all cases. Patients had their BP measured four times a day, fetal heart sound twice a day, fetal 
grown monitoring via ultrasound every two weeks. Ultrasonography was used to determine gestational age. 
• 12 patients reached 36 weeks (5 were 32 weeks, 3 were 33 
weeks, and 4 were 34 weeks at recruitment) 
• Of the 16 patients who were <30 weeks at recruitment, only 1 
baby survived. 
• Intrauterine death occurred in 19 cases 
• Conclusion: in selected cases, with close monitoring and 
supervision, after 30 weeks gestation, conservative 
management can be attempted; further controlled trials with 
larger sample size in needed to determine protocol. 
Begum, Begum, & 
Quadir, (2002) 
July—November 1999: Randomized trial 
Eclamptic patients at Dhaka Medical College Hospital without contraindications were randomized to receive either 
only the loading dose (n=202 women given 4g (8mL dissolved in 12mL distilled water) through IV, and 6g IM in 
• There was no significant difference in intervals form fit and 
treatment or fit and delivery between the groups. 
• Recurrent convulsion rates were also not statistically 
significant: control (3.52%) vs. study group (3.96%). 
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Citation Study Design & Methods Main Findings and Conclusions 
two buttocks)) or the standard regime (n=199 women given (4g IV, 6g IM followed by 2.5g IM every 4h in 
alternating buttocks for 24h)). 
Both groups were managed the same way (ex: High BP >110mmHg was treated with hydralazine). 
Recurrent convulsions in both groups were managed with 2.5g IV and regular maintenance doses. 
• Stillbirth rates and rates of cesarean sectionwere 
comparable. 
• Conclusion: a loading dose alone of MgSO4 is as effective as 
loading dose followed by maintenance doses to control and 
prevent convulsions due to eclampsia. 
Begum, Quadir, 
Begum, Akhter, & 
Rahman, (2002) 
June 1999—June 2000: Comparative study. 
Patients with eclampsia and hypertensive emergencies receiving MgSO4 for seizure prophylaxis were recruited and 
enrolled at Dhaka Medical College and Hospital. 
Group A (n=44) received IV bolus hydralazine. 5mg initially administered then 2 mg at 15 minute intervals. 
Group B (n=33) given official protocol of IV drip of hydralazine. 10 drops/minute then increased by 5 drops at 15 
min intervals. 
BP was recorded every 5 minutes in the first hour and every 15 minutes after that until BP stabilized. 
• Group A achieved therapeutic blood pressure goal within 
65.23 minutes + 23.38 minutes compared to Group B which 
required 186.36 minutes + 79.77  
• Group A also required lower doses of hydralazine (6.68 + 
1.66 mg) compared to group B (20.07 + 11.38 mg) 
• There were no adverse maternal effects in either group. 
• This study found that direct injection was more effective than 
drip. 
Begum (2001) March 25—June 15 1998: Prospective experimental study 
65 participants at Dhaka Medical College and Hospital were admitted and treated using the regime from the 
“Dhaka study” which involved: 5g MgSO4 given slowly by IV over 15 minutes with 3g IM in each buttock as the 
loading dose, followed by 2.5g IM in alternate buttocks every hour for 24 hours. 
Patients were monitored every 30 minutes for the first six hours and every hour after that; respiratory rate, knee 
jerks and urinary output were observed closely as well as blood samples tested for serum magnesium levels. 
• 63% had antepartum and 2 (3%) were intrapartum.   
• There were no maternal deaths and only one patient had 
recurrent convulsions and was treated with 10mg of IV 
diazepam. 
• Eight stillbirths, and three newborn deaths within the first 
week; 45% were low birth weight 
• Low dose ‘Dhaka’ regime seems to control and prevent 
recurrent convulsions effectively  
Begum (2013) January—December 2011: Prospective cohort study 
100 eclamptic women from Dhaka Medical College and Hospital who were term, were included in the study. 
Patients were delivered either vaginally (Group I, n=50) or by cesarean section (CS) (Group II, n=50).   
Patient’s history was taken, urine tested for protein, convulsions controlled with MgSO4, BP was controlled using 
hydralazine, nifedipine or methyldopa. 
Maternal, fetal, and neonatal outcomes were recorded and analyzed. 
• Maternal mortality in group I (vaginal) was 6% compared to 
100% survival among group II (CS) group 
• Still birth rates and birth asphyxia were higher in group I when 
compared to CS group. (Group I: 20% stillbirth, 60% birth 
asphyxia; Group II: 6% stillbirth, 23.4% birth asphyxia) 
• Better fetomaternal outcomes were observed in the group 
that was delivered via CS  
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Annex I:  
INTERVENTIONS ON PREVENTION, DETECTION OR TREATMENT OF PE/E 
Citation Study Design Location/ dates/ sample size-study 
population 
Methods Main Findings/ limitations/conclusions 
Banu, M., Akter, M., Begum, K., 
Choudhury, R. H., & Nasreen, H. E. 
(2014). “The clock keeps ticking”--
the role of a community-based 
intervention in reducing delays in 
seeking emergency obstetric care 
in rural Bangladesh: a quasi-
experimental study. Public Health, 
128(4), 332–40. 
Quasi-
experimental 
study 
4 intervention districts (Nilphamari, 
Rangpur, Gaibandha and 
Mymensingh) 
2 control districts (Netrokona and 
Naogaon) 
 
January—February 2010 
 
Intervention: 200 women per district 
(800 women) 
 
Control: 200 women per district (400 
women) 
540 villages received BRAC’s core interventions 
(education, water and sanitation, microfinance 
assistance, essential health care, health and 
nutrition education, family planning, 
immunization, pregnancy care and vitamin A 
supplementation) 
 
Intervention group received intensive maternity 
care and the intervention focused on developing 
competency of CHWs, community empowerment, 
rendering homestead health services, and 
establishing referral linkages with government 
and non-government health facilities.  
• Defined eclampsia as “convulsion in 
pregnancy/delivery/after delivery; fell unconscious; 
tongue bite, frothy discharge from mouth; 
BP>140/90mmHg on antenatal care card or 
doctor’s prescription; pain in abdomen, severe 
headache, blurred vision; swelling of 
face/hands/legs/genital organs.” 
• 90% of obstetric emergencies in intervention group 
sought EmOC compared to 52% in control group 
• 7.4% of women in intervention group experienced 
eclampsia, and had a median time to decide to seek 
care of 65 minutes 
• 3.8% of comparison group experienced eclampsia 
and had a median time to decide to seek care of 47 
minutes 
 
Basu, M., Begum, H., Karim, M. A., 
& Rahman, M. (2006). 
RANDOMISED COMPARISON OF 
GENERAL ANAESTHESIA & 
SUBARACHNOID BLOCK FOR 
CAESAREAN DELIVARY IN 
PREGNANCIES COMPLICATED BY 
ECLAMPSIA. Journal of BSA, 
19(1&2), 44–50. 
Randomized 
comparison 
Dhaka Medical College Hospital 
 
January 2001—December 2001 
 
60 women with eclampsia  
Only women with eclampsia (convulsion, 
hypertension, proteinuria) were included. Cases 
of eclampsia were managed with MgSO4 and 
Hydralazine was given to lower BP over 110 
mmHg 
• 4gm IV and 6g IM given of MgSO4 
• Women with eclampsia, requiring cesarean 
sectionwere randomized into groups receiving 
either general anesthesia or spinal anesthesia 
• Preoperative, perioperative and postoperative 
parameters and tests were assessed and data were 
analyzed.  
• There was no significant difference in average 
highest BP, Glasgow coma score 24 hours after 
operation, birth weight. 
• Potential advantages of spinal anesthesia are early 
induction to delivery and better Apgar score of the 
infant, which may make spinal anesthesia as good a 
choice for eclamptic CS deliveries as general 
anesthesia. 
Baxter, J.-A. B., Roth, D. E., Al 
Mahmud, A., Ahmed, T., Islam, M., 
& Zlotkin, S. H. (2014). Tablets are 
preferred and more acceptable 
than powdered prenatal calcium 
supplements among pregnant 
women in Dhaka, Bangladesh. The 
Discrete-
choice 
experimental 
design 
Shimantik Maternity Centre, Khilgao, 
Dhaka 
 
November 2012 to March 2013 
 
Pregnant women aged 18-39 years and 
gestational age of 13-30 weeks were recruited.  
 
Participants were given four choices for calcium 
supplementation: conventional tablets, chewable 
tablets, unflavored powder and flavored powder, 
each providing a daily dose of 1500 mg Ca. 
• WHO guidelines for prevention of PE “routine 
prenatal calcium supplementation with 1.5 to 2.0g 
of elemental calcium per day for women with low 
calcium diets. This study set out to assess the 
preference and acceptability of four different delivery 
vehicles for prenatal calcium supplementation 
• After primary analysis, conventional tablets (62%) 
were most chosen followed by, chewable tablets 
(19%), flavored powder (12%), unflavored powder 
(5%), none (2%) 
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Journal of Nutrition, 144(7), 1106–
1112. 
149 enrolled, 17 withdrew prior to 
selection period, 2 withdrew before 
completing follow up 
 
132 women after run-in period 
 
130 women at end of study 
 
During a 4 day “run-in period” each participant 
was able to sample each option before making 
her selection—this period lasted 21 days;, she 
was able to choose any of the four options 
independent of her previous choice(s). 
 
Semi-structured questionnaires were conducted 
following the run-in period and after the selection 
period to assess various aspect which may have 
affected preference/choice (including taste, 
mouth feel, aftertaste, odor, size, ease of use) 
• 93% of participants selected conventional tablets at 
least once during the selection period,  
• Conventional tablets were the most chosen vehicle 
for every day of the study. 
Begum, M. R., Akhter, S., Begum, 
A., Khatun, M., Quadir, E., & 
Choudhury, S. B. (2002). 
Conservative management of 
eclampsia and severe pre-
eclampsia--A Bangladesh 
experience. Medscape Women’s 
Health, 7(1), 1. 
 Dhaka Medical College and Hospital 
 
January 1998—October 2000 
 
21 patients with PE and 30 patients 
with E; all <36 weeks 
Participants were admitted into the Eclampsia 
Unit and given 4g IV MgSO4 administered slowly, 
and 3g IM in each buttock followed by 2.5g IM in 
alternate buttocks every 4 hours for 24 hours. 
They were put on bed rest, given oral 
phenobarbitone and an antihypertensive 
(methyldopa, hydralazine, nifedipine). All patients 
underwent 24-hour urine collection for 
measurement of urinary total protein. Serum 
urea, creatinine, uric acid platelet count, SGOT 
and SGPT were measured for all cases. 
Ultrasonography was used to determine 
gestational age, 
• Conservative management was intended to prolong 
pregnancy until 36 weeks gestation or until maternal 
or fetal complications began to develop.  
• Patients had their BP measured four times a day, 
fetal heart sound twice a day, fetal grown monitoring 
via ultrasound every two weeks  
• 12 patients reached 36 weeks (5 were 32 weeks, 3 
were 33 weeks, and 4 were 34 weeks at 
recruitment) 
• Of the 16 patients who were <30 weeks at 
recruitment, only 1 baby survived. 
• Intrauterine death occurred in 19 cases 
• Conclusion: in selected cases, with close monitoring 
and supervision, after 30 weeks gestation, 
conservative management can be attempted; further 
controlled trials with larger sample size in needed to 
determine protocol. 
Begum, M. R., Begum, A., & Quadir, 
E. (2002). Loading dose versus 
standard regime of magnesium 
sulfate in the management of 
eclampsia: A randomized trial. 
JOURNAL OF OBSTETRICS AND 
GYNAECOLOGY RESEARCH, 28(3), 
154–159. 
Randomized 
trial 
Dhaka Medical College and Hospital 
 
July 1999—November 1999 
 
Only loading dose: 202 women 
 
Standard regimen: 199 women 
Eclamptic patients without contraindications 
were randomized to receive either only the 
loading dose (4g (8mL dissolved in 12mL distilled 
water) through IV, and 6g IM in two buttocks) or 
the standard regime (4g IV, 6g IM followed by 
2.5g IM every 4h in alternating buttocks for 24h) 
 
Both groups were managed the same way (ex: 
High BP >110mmHg was treated with 
hydralazine) 
 
• There were no significant differences between the 
two groups clinical symptoms or clinical history (BP, 
edema, albuminuria)  
• There was no significant difference in intervals form 
fit and treatment or fit and delivery between the 
groups. 
• Recurrent convulsion rates were also not statistically 
significant: control (3.52%) vs. study group (3.96%) 
• Stillbirth rates and rates of cesarean 
sectionwere comparable  
• This study indicated that a loading dose alone of 
MgSO4 is as effective as loading dose followed by 
maintenance doses to control and prevent 
convulsions due to eclampsia. 
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Recurrent convulsions in both groups were 
managed with 2.5g IV followed by regular 
maintenance doses  
Begum, M. R., Quadir, E., Begum, 
A., Akhter, S., & Rahman, K. (2002). 
Management of hypertensive 
emergencies of pregnancy by 
hydralazine bolus injection vs 
continuous drip - A comparative 
study. MEDSCAPE WOMENS 
HEALTH, 7(5). 
Comparative 
study 
Dhaka Medical College and Hospital 
 
June 1999—June 2000 
 
77 patients with eclampsia and 
hypertensive emergencies 
Patients were receiving MgSO4 for seizure 
prophylaxis at enrollment.  
 
Group A (n=44) received IV bolus hydralazine. 
5mg initially administered then 2 mg at 15 
minute intervals 
 
Group B (n=33) given official protocol of IV drip of 
hydralazine. 10 drops/minute then increased by 
5 drops at 15 min intervals. 
 
BP was recorded every 5 minutes in the first hour 
and every 15 minutes after that until BP 
stabilized  
• Hypertensive emergency was defined as “a 
sustained systolic blood pressure (SBP) of > 170 
mmHg or DBP > 115 mmHg repeated 15 minutes 
apart  
• Group A achieved therapeutic blood pressure goal 
within 65.23 minutes + 23.38 minutes compared to 
Group B which required 186.36 minutes + 79.77  
• Group A also required lower doses of hydralazine 
(6.68 + 1.66 mg) compared to group B (20.07 + 
11.38 mg) 
• There were no adverse maternal effects in either 
group. 
• This study found that direct injection was more 
effective than drip. 
 
Begum, R., Begum, A., Johanson, 
R., Ali, M. N., & Akhter, S. (2001). A 
low dose (’Dhaka') magnesium 
sulphate regime for eclampsia - 
Clinical findings and serum 
magnesium levels. ACTA 
OBSTETRICIA ET GYNECOLOGICA 
SCANDINAVICA, 80(11), 998–
1002. 
Prospective 
experimental 
study 
Dhaka Medical College and Hospital 
 
March 25—June 15 1998 
 
65 patients with antepartum or 
intrapartum eclampsia 
Participants were admitted and treated using the 
regime from the “Dhaka study” which involved: 
5g MgSO4 given slowly by IV over 15 minutes with 
3g IM in each buttock as the loading dose, 
followed by 2.5g IM in alternate buttocks every 
hour for 24 hours. 
Patients were monitored every 30 minutes for the 
first six hours and every hour after that; 
respiratory rate, knee jerks and urinary output 
were observed closely as well as blood samples 
tested for serum magnesium levels.  
• 63% had antepartum and 2 (3%) were intrapartum.   
• There were no maternal deaths and only one patient 
had recurrent convulsions and was treated with 
10mg of IV diazepam  
• Eight stillbirths, and three newborn deaths within the 
first week (due to low birth weight) 
• 45% of babies were low birth weight 
• Low dose ‘Dhaka’ regime seems to control and 
prevent recurrent convulsions effectively and serum 
level remain below toxic levels.  
Begum, S., Islam, F., & Jahan, A. A. 
(2013). Feto-maternal Outcomes in 
Cesarean Section Compared to 
Vaginal Delivery in Eclamptic 
Patients in a Tertiary Level Hospital. 
Journal of Enam Medical College, 
3(2), 77–83. 
Prospective 
cohort study 
Dhaka Medical College & Hospital 
 
January—December 2011 
 
Group I, 50 patients with vaginal 
delivery 
 
Group II, 50 with cesarean section 
100 eclamptic women who were term, were 
included in the study. 
 
Patients were delivered either vaginally or by 
cesarean section (CS).   
 
History of patient was taken, urine tested for 
protein, convulsions controlled with MgSO4, BP 
was controlled using hydralazine, nifedipine or 
methyldopa. 
• “Eclampsia is the occurrence of convulsion in 
association with the features of pre-eclampsia. Pre-
eclampsia is a multisystem disorder that is usually 
associated with hypertension and proteinuria” 
• Diagnostic criteria: “high blood pressure (>140/90 
mmHg), significant proteinuria and convulsion 
associated with pregnancy more than 20 weeks of 
gestation” 
• Maternal mortality in group I (vaginal) was 6% 
compared to 100% survival among group II (CS) 
group 
• Still birth rates and birth asphyxia were higher in 
group I when compared to CS group. (Group I: 20% 
stillbirth, 60% birth asphyxia; Group II: 6% stillbirth, 
23.4% birth asphyxia) 
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Maternal, fetal, and neonatal outcomes were 
recorded and analyzed. 
• Better fetomaternal outcomes were observed in the 
group that was delivered via CS  
Herrera, J. A., Arévalo-Herrera, M., 
Shahabuddin, A. K. M., Ersheng, G., 
Herrera, S., Garcia, R. G., & López-
Jaramillo, P. (2006). Calcium and 
conjugated linoleic acid reduces 
pregnancy-induced hypertension 
and decreases intracellular 
calcium in lymphocytes. American 
Journal of Hypertension, 19(4), 
381–7. 
Randomized, 
double-blind 
pacebo-
controlled 
trial 
Bangladesh & Columbia 
 
50 participants randomized, 2 lost to 
follow up 
Healthy primigravidas who were younger than 19 
or older than 35, who were between 18 and 22 
weeks gestation were recruited.  
 
Participants were deemed “high risk” if they had 
family history of PE and had an “abnormal finding 
(e.g., a diastolic notch in uterine or arcuate artery 
waveforms) on Doppler ultrasonographic 
examination”. 
 
Participants were randomized into one of two 
groups: the study group received a daily dose of 
1484 mg of calcium carbonate (600 mg of 
elemental calcium) and 450 mg of CLA  
 
Placebo group received lactose and starch pills  
• Incidence of PIH was significantly reduced in the 
study group (8.3%) compared to placebo group 
(41.7%) 
• The concentration of intracellular ionized free 
calcium was reduced in the study group compared to 
placebo group. 
• “Calcium and CLA supplementation during pregnancy 
reduced the incidence of PIH, and decreases the 
intracellular concentration of ionized free calcium in 
peripheral blood lymphocytes” 
Herrera, J. A., Shahabuddin, A. K. 
M., Ersheng, G., Wei, Y., Garcia, R. 
G., & López-Jaramillo, P. (2005). 
Calcium plus linoleic acid therapy 
for pregnancy-induced 
hypertension. International Journal 
of Gynaecology and Obstetrics: The 
Official Organ of the International 
Federation of Gynaecology and 
Obstetrics, 91(3), 221–7. 
Randomized, 
double-blind 
pacebo-
controlled 
trial 
Bangladesh & Columbia 
 
50 participants randomized, 2 lost to 
follow up 
Healthy primigravidas who were younger than 19 
or older than 35, who were between 18 and 22 
weeks gestation were recruited.  
 
Participants were deemed “high risk” if they had 
family history of PE and had an “abnormal finding 
(e.g., a diastolic notch in uterine or arcuate artery 
waveforms) on Doppler ultrasonographic 
examination”. 
 
Participants were randomized into one of two 
groups: the study group received a daily dose of 
1484 mg of calcium carbonate (600 mg of 
elemental calcium) and 450 mg of CLA  
 
• Overall incidence of PIH was significantly decreased 
in the study group (2 cases, 8%) compared to 
placebo group (10 cases, 42%); PE incidence was 
also higher among placebo group (12.5%, 3 cases) 
compared to zero cases in the study group. 
• Mean maternal diastolic BP at delivery was 
significantly higher among placebo group and mean 
birthweight was significantly higher among study 
group. 
• cesarean sectionrate was similar in the two 
groups 
• Calcium-CLA supplementation decreases incidence 
of PIH and “improved vascular endothelial function in 
pregnant women with low baseline calcium intake 
and additional risk factors” 
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Placebo group received lactose and starch pills  
Islam, K. S., Sachchu, S. A., 
Sandani, R., Bullough, C., Siraj, N., 
Dimmock, P., & Johanson, R. B. 
(2001). Using village theatre to 
increase knowledge about 
eclampsia in Bangladesh. The 
Journal of Obstetrics and 
Gynaecology Research, 27(4), 
199–204. 
Pre and post  
 
 
15 men, 15 women 
Randomly selected audience members (15 men, 
15 women) answered questions about eclampsia 
prior to watching scenarios performed by a 
theatre company related to eclampsia. The same 
audience members were asked the same 
questions after the performance. 
• The questions included: what is eclampsia? Who 
suffers from eclampsia? What are the symptoms of 
eclampsia? Who is the best person to treat 
eclampsia? At what stage of pregnancy idoes 
eclampsia affect a woman?  
• 4/30 (13%) knew of someone dying of eclampsia, 
however after the performance, 17/30 (57%) 
remembered cases fitting the symptoms 
• After the village theatre performance, the villages 
had raised awareness and knowledge relating to 
eclampsia and treatment for eclampsia.  
Shamsuddin L, Nahar K, Nasrin B, 
Nahar S, Tamanna S, Kabir RMA, et 
al. Use of parenteral magnesium 
sulphate in eclampsia and severe 
pre-eclampsia cases in a rural set 
up of Bangladesh. Bangladesh Med 
Res Counc Bull. Bangladesh; 2005 
Aug;31(2):75–82. 
Quasi-
experimental 
interventional 
study 
Modhupur Upazila, Tangail, Madanpur 
Upazila, Netrokona, and Malandar 
Upazila of Jamalpur 
 
July 2001—December 2001 
 
265 cases; 133 intervention, 132 non-
intervention group 
Intervention: patients with severe PE/E who 
received loading dose of MgSO4 at home before 
being referred to hospital 
 
Non-intervention: patients with severe PE/E 
arriving directly at hospital (not receiving MgSO4 
at home). 
 
Participants were more than 28 weeks pregnant 
with BP 140/100 mmHg, urine output at least 
30ml/h and respiratory rare more than 16 
per/minute. 
 
Field workers increased community awareness, 
identified patients and assessed their condition 
and communicate with “focal persons” and 
“reserve doctors” 
 
Focal persons were responsible for diagnosing 
and assessing conditions and giving loading dose 
at home and referring to nearest facility.  
 
Doctors covered the Thana Health Complex 
24hours on a rotation basis. 
• 72% of intervention group and 63% of non-
intervention group were primigravida. 
• 91% in intervention group and 91.5% of non-
intervention group had no ANC 
• Clinical data were recorded for all participants prior 
to any injection 
• During observation at hospital, 6% of intervention 
group experienced recurrent fits and 25.8% of non-
intervention group experienced recurrent fits. 
• Control of convulsions was 94% for intervention 
group and 74.2% for non-intervention group. 
• There were 3 (2.3%) maternal deaths in intervention 
group and 14 (10.6%) in non-intervention group.  
• Proportion of patients who experienced 
complications was also statistically significant 
between the groups (intervention group = 23 (17.3%) 
and non-intervention = 36 *27.3%). 
• 86% of intervention babies were born alive and 80% 
non-intervention babies. 14% of intervention women 
delivered stillborn babies compared to 20% in non-
intervention cases 
• Conclusions: this study showed that reducing the 
time until the first injection can reduce negative 
health outcomes for mother and baby. 
Sultana N, Begum K, Begum A, 
Akhter U. A lower dose of 
magnesium sulphate for control of 
convulsion in eclamptic women of 
Bangladesh. Bangladesh J Obstet 
Prospective 
randomized 
case-control 
study 
Dhaka Medical College Hospital 
 
June 2007-May 2008 
Women with antepartum or intrapartum 
eclampsia were divided randomly into two groups 
and gave detailed history. CBC, total urinary 
protein, blood urea, serum creatinine, uric acid, 
FDP, fibrinogen level, serum electrolyte, platelet 
• There was no statistical significance in recurrence 
rates of convulsions between the two groups.  
• The time required to regain consciousness after 
initiation of treatment did not differ significantly 
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Gynaecol [Internet]. 
2010;25(2):71–6. 
 
100 patients: 
Group A: (n=48)  8g magnesium 
sulphate heptahydrate (Nalepsin) IV 
route 
 
Group B: (n=52)10g magnesium 
sulphate (4g IV slowly than 3 g IM in 
each buttock) conventional treatment 
count, and liver function test were performed for 
all participants.  
 
Injection hydralazine (20mg in 200ml of 5% 
dextrose in aqua) was given in continuous IV drip 
when required to control BP.  
• Blood pressure levels upon admission and at 
discharge were also not significantly different. 
• There was no significant difference between the 
rates of maternal complication or maternal death 
between the two groups. 
• This study concluded that 8g MgSO4 heptahydrate 
(2bags Nalepsin) can effectively control convulsions 
in eclamptic patients. 
Yousuf N, Hussain M, Begum K. 
Comparative Study of Urinary 
Albumin Excretion in Pre-Eclamptic 
Women in Different Duration. 
Bangladesh Med J. 
2011;40(3):33–6. 
Cross 
sectional 
Bangabandhu Sheikh Mujib Medical 
University and Dhaka Medical College 
Hospital  
 
November 2004-February 2005 
 
40 pregnant women with PE 
 
Detailed medical and obstetric history was taken 
and examinations performed for all participants.  
 
Urine was collected during 12 hour day collection 
and 12 hours night collection. The two samples 
were tested separately and also combined for a 
24 hour collection sample. 
• PE = “hypertension (140/90 mmHg or more) after 
20th week of gestation and a bed side urine albumin 
positive.” 
• The albumin excretion did not differ significantly 
between 12 hour day, 12 hour night and 24 hour 
samples.  
• 12 hour night sample was in closer agreement with 
24 hour collection. 
 
• *poor quality paper. 
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Afroj, S. (2009). Maternal and 
Foetal Outcome of Eclampsia in 
Mymensingh Medical College 
Hospital. Journal of Shaheed 
Suhrawardy Medical College, 1(1), 
14–17. 
Prospective 
cross-sectional 
study 
Mymensingh Medical 
College Hospital 
 
Nov. 2002 –April 2003 
 
212 eclampsia patients 
Eclampsia patients who 
were admitted to the ward 
and stayed for at least 
seven days. Data were 
collected from participants 
using a questionnaire 
• Incidence of eclampsia: 4.1% (5175 admissions); CFR= 5% 
• After diagnosis, MgSO4 was used to control convulsions and 
hydralazine and other oral antihypertensives were used to treat 
severe hypertension 
• 50% of cases were antepartum, 26.5% intrapartum, and 23.5% 
postpartum 
• 51.5% <20 years old, 
• 47 fetal deaths were recorded. 
• Recommend development of eclampsia units equipped with ICU 
facilities and staff well-trained to deal with eclampsia patients 
Akhtar, R., Ferdous, A., & Bhuiyan, 
S. N. (2011). Maternal and Fetal 
Outcome of Eclamptic Patients in a 
Tertiary Hospital. Bangladesh 
Journal of Obstetrics & 
Gynaecology, 26(2), 77–80. 
Prospective 
cross sectional 
study 
Chittagong Medical 
College and Hospital 
 
January—December 
2010 
 
416 eclampsia patients 
Data collected from 
patients and their 
companions (if patient 
unconscious) using a 
questionnaire and 
interview. Data analyzed 
using a calculator. 
• Incidence of eclampsia= 3.05%; CFR= 8.4% 
• Eclampsia “the occurrence of convulsions during pregnancy or in 
the first 10 days postpartum with at least two of the following 
features within 24 hours after convulsion-A) Hypertension (DBP > 
90mm of Hg) B) Proteinuria (at least 3 plus protein in random urine 
sampling or more than 3 gram[sic] in a 24 hour urine collection) C) 
Thrombocytopenia (platelet count of <100 x 109) or raised serum 
aspartate” 
• 72.5% were primigravida, 76% were from rural areas, 60% of 
eclamptic patients had no ANC, 52% were admitted more than six 
hours after eclamptic attack, 62.5% were delivered via CS, 18% of 
deliveries were stillborn, and 9% experienced early neonatal death.  
• Conclusion: eclampsia is preventable if PE is detected during ANC; 
increase awareness on importance of ANC and use MgSO4 to 
reduce maternal mortality and morbidity 
Akhter, S., Habib, J., & Sultana, S. 
(2008). A STUDY OF LATE 
POSTPARTUM ECLAMPSIA- 178 
CASES. Bangladesh Medical 
Journal, 37(2), 52–55. 
Cross sectional Dhaka Medical College 
Hospital 
 
January 2006—
December 2007 
 
98 patients w/ 
eclampsia 
Records for all patients who 
had eclamptic convulsions 
were retrieved and 
demographic information 
as well as timing of first 
seizure, and other clinical 
details were analyzed. 
• Eclampsia “the onset of convulsions in women with clinical signs 
and symptoms that were consistent with preeclampsia” 
• Late postpartum eclampsia: “the onset of convulsions >48 hours 
after delivery” 
• This study looked at the timing of eclampsia onset and whether 
“traditional symptoms precede impending postpartum eclampsia” 
• They consider cases where women experienced typical symptoms: 
blurred vision, headache, nausea etc., could have been prevented, 
but those who showed no known risk factors were not preventable. 
 
This paper was not clearly written; it simultaneously says that 23 and 46 
women developed late onset postpartum eclampsia during the study 
period. The results were poorly organized and presented in a confusing 
manner. 
Ashraf, F., Mustanzid, S. M., & 
Khanom, M. (2007). Maternal 
Mortality in a District Hospital of 
 Kushtia General 
Hospital 
 • 32 (86.48%) of maternal deaths were due to eclampsia, 3 (8.1%) 
ruptured uterus with shock and 1 (2.7%) was due to incomplete 
abortion. 
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Bangladesh An In-Depth Search of 
the Underlying Causes. The Journal 
of Teachers Association, 20(2), 99–
106. 
 
August 1999—July 2000 
 
37 maternal deaths 
• Suggests increasing literacy, changing attitudes, delaying marriage, 
and delaying first conception can help reduce maternal mortality. 
Begum, R., Begum, A., Bullough, C. 
H., & Johanson, R. B. (2000). 
Reducing maternal mortality from 
eclampsia, using magnesium 
sulphate. European Journal of 
Obstetrics, Gynecology, and 
Reproductive Biology, 92(2), 223–
224. 
Retrospective 
case review 
Dhaka Medical College 
 
January 1997—June 
1998 
 
 
 
 
Data collected 
retrospectively from 
patients admitted to 
Eclampsia Unit. 
• 1997, diazepam was the sole anticonvulsant used for 522 
patients, 81 died (16% mortality rate) 
• Jan-June 2008, 327 eclamptic patients were admitted and treated 
with MgSO4 and 25 died (8%) 
• The reduced mortality associated with MgSO4 will benefit women in 
developing countries 
• Use of MgSO4 must be promoted in Bangladesh to get obstetricians 
to accept it over diazepam.  
Begum, M. R., Begum, A., Quadir, 
E., Akhter, S., & Shamsuddin, L. 
(2004). Eclampsia: still a problem 
in Bangladesh. MedGenMed : 
Medscape General Medicine, 6(4), 
52. 
Descriptive Dhaka Medical College 
and Hospital 
 
1998—2000 
 
2956 cases of 
eclampsia 
 • Incidence of eclampsia: 9% 
• Eclampsia: high blood pressure (up to 140/90 mmHg), edema, 
proteinuria, and convulsion associated with pregnancy after 20 
weeks gestation.  
• Antepartum/intrapartum made up 80% of cases, 20% were 
postpartum 
• Other complications associated with eclampsia were: renal failure, 
hepatic failure, heart failure, cerebrovascular accident and coma, 
pulmonary edema, HELLP syndrome, and abruptio placenta.  
• Of the patients with complications, 98% died 
Begum, N., & Ferdousi, R. (2014). 
Study of Gross Anatomy of Human 
Placenta in Pregnancy Induced 
Hypertension. JAFMC Bangladesh., 
10(2), 55–61. 
Descriptive, 
observational 
study 
Department of Anatomy, 
Bangabandhu Sheikh 
Mujib Medical University 
 
July 2003—June 2004 
 
40 placentas (20 non 
hypertensive mothers, 
and 20 from PIH 
mothers) 
Placentas were collected 
from mothers who 
delivered live born babies 
through CS. 
 
Placenta was inspected for 
any abnormalities 
(infarction, hematoma, and 
calcification) shape weight 
were recorded. 
• Gestational hypertension = maternal BP > 140/90mmHg 
• PE = “hypertension associated with either significant proteinuria or 
maternal organ dysfunction or both.” 
• The PIH group had lower mean gestational age 37.55 + 1.23 
compared to control group 38.1+ 1.02)  
• The analysis of the placentas from the two groups showed no 
significant differences in: blood group, weight and volume, 
diameter, thickness and number of cotyledon. 
• This study did not identify any statistically significant changes in 
placentas from the PIH group 
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Fronczak, N., Antelman, G., Moran, 
A. C., Caulfield, L. E., & Baqui, A. H. 
(2005). Delivery-related 
complications and early 
postpartum morbidity in Dhaka, 
Bangladesh. International Journal 
of Gynaecology and Obstetrics: The 
Official Organ of the International 
Federation of Gynaecology and 
Obstetrics, 91(3), 271–8. 
Prospective 
community-
based study 
Slums of Dhaka city 
 
November 1993—May 
1995 
 
1506 women who 
experienced delivery-
related complications/ 
postpartum morbidities 
Women were interviewed in 
their homes on four 
occasions: at 7 months 
gestation, 72h postpartum, 
7 days and 14-22 days 
postpartum. 
 
Participants were asked 
open-ended questions, 
followed by specific 
questions on symptoms of 
complications or 
morbidities experienced 
and care seeking behavior. 
At 14-22 days postpartum, 
physical examinations were 
performed.  
• “non-convulsive hypertensive disorder of pregnancy (pre-
eclampsia)” = two of the following: “non-dependent edema, 
headache, or dizziness, where symptoms began only during the last 
trimester of pregnancy” 
• 9% of women reported having PE as a delivery-related complication 
and 1% reported eclampsia—primipara women were more likely to 
experience eclampsia. 
• 11% of women were diagnosed as having hypertension 14-22 days 
postpartum 
 
Halim, A., Utz, B., Biswas, A., 
Rahman, F., & van den Broek, N. 
(2014). Cause of and contributing 
factors to maternal deaths; a cross-
sectional study using verbal 
autopsy in four districts in 
Bangladesh. BJOG-AN 
INTERNATIONAL JOURNAL OF 
OBSTETRICS AND GYNAECOLOGY, 
121(4, SI), 86–94. 
Cross-sectional Thakurgaon, Jamalpur, 
Moulvibazar, Narail 
districts 
 
January 2011—
December 2012 
 
571 maternal deaths 
Verbal Autopsy was 
conducted using a 30 
question survey with 
response categories on 
sociodemographic 
information, reproductive 
history, complications 
during pregnancy, ANC and 
birth-preparedness, 
healthcare-seeking 
behavior for delivery, 
complications during 
delivery and postpartum, in 
addition to referral and 
delay details. 
 
All VAs were conducted 
within 15-30 days of the 
death with three 
respondents (family 
members and/or TBA who 
had provided care) 
• 571 maternal deaths were identified, 273 (47.8%) women died at 
the health facility and 298 women died at home or on the way to 
the facility 
• PE/E was the second most frequently identified cause of death, 
contributing 20% of maternal deaths in this study. 
• A higher proportion of facility deaths (22.7%) were attributed to 
eclampsia compared to community deaths (17.4%) 
• Two peaks were observed related to PE/E deaths: during 
immediate postpartum period and 8-14 days after delivery 
Hossain, S., Mondal, M. K., Roy, B. 
R., & Akter, J. (2011). Effect of 
magnesium sulphate on quality of 
subarachnoid block in terms of 
Case control 
Study 
Dhaka Medical College 
and Hospital 
 
Participants were divided 
into two groups: (A: normal 
parturient and B: 
• Pulse rate, systolic blood pressure, and onset of sensory motor 
block was significantly different between the women in the two 
study groups  
 39 
 
Citation Study Design Location/ dates/ sample 
size-study population 
Methods Main Findings/ limitations/conclusions 
onset and duration of motor and 
sensory block, APGAR score of the 
neonate and haemodynamic status 
of the patient. Journal of the 
Bangladesh Society of 
Anaesthesiologists, 24(2), 41–47. 
  
 
60 participants 
undergoing CS under 
“subarachnoid block” 
preeclamptic parturient 
treated with MgSO4) 
 
Pulse rate and BP were 
regularly monitored and 
measured. Target systolic 
arterial pressure 
>90mmHg; if SAP<90 
mmHg, IV infusion of 
crystalloid and ephedrine 
injection given as needed 
• Patients who received MgSO4 had a higher risk of developing 
hypotension and deliver babies with low, but acceptable APGAR 
scores 
• This study concluded that spinal anesthesia is safe in preeclamptic 
women treated with MgSO4 
Huda, F. A., Ahmed, A., Dasgupta, S. 
K., Jahan, M., Ferdous, J., 
Koblinsky, M., … Chowdhury, M. E. 
(2012). Profile of maternal and 
foetal complications during labour 
and delivery among women giving 
birth in hospitals in Matlab and 
Chandpur, Bangladesh. Journal of 
Health, Population and Nutrition, 
30(2), 131–142. 
 Icddr,b Matlab 
 
2007—2008 
 
4,817 deliveries 
Information on maternal 
complications was 
collected from women 
delivering in the icddr,b 
service area in matlab.  
• 62.5% delivered in facilities, 37.5% delivered at home 
• HDP “Eclampsia (seizures associated with hypertension, i.e. 
diastolic blood pressure > 110 mmHg) and severe pre-eclampsia 
(hypertension with proteinuria >2 ++, blurred vision, or 
hyperreflexia) 
• Severe PE/E were considered to be severe maternal complications 
• HDP was diagnosed in 12.6% of deliveries 
Kalim, N., Anwar, I., Khan, J., Blum, 
L. S., Moran, A. C., Botlero, R., & 
Koblinsky, M. (2009). Postpartum 
haemorrhage and eclampsia: 
differences in knowledge and care-
seeking behaviour in two districts of 
Bangladesh. Journal of Health, 
Population, and Nutrition, 27(2), 
156–169. 
Mixed methods Khulna and Sylhet (four  
Sub districts from these 
two divisions) 
 
July 2006—December 
2007 
 
80 participants 
20 from each age group 
and each district 
Qualitative (free-listing, 
rating exercises, 
hypothetical case scenarios 
and in-depth interviews) to 
determine commonly 
perceived complications, 
relative perceived severity, 
knowledge on signs and 
symptoms, care-seeking 
behaviors. 
 
Participants were women of 
reproductive age (15-49) 
and older women (50-70) 
who had at least one birth 
experience 
• 20 participants reported eclampsia as a perceived complication 
relating to labor, delivery and the postpartum period included 
• Perceived causes and signs/symptoms included: cold, weakness 
due to malnutrition, high BP, evil spirit 
• Decision to seek care was said to be made by elderly family 
members and was often delayed even when bleeding was present. 
• In Sylhet, evil spirits, high blood pressure and blood deficiency were 
cited as causes of eclampsia 
• In Jessore, high blood pressure, swollen body, malnutrition and evil 
spirits were listed as the evil spirits 
• General care-seeking patterns were similar at all sites and women 
face similar barriers (distance, transportation, restricted movement 
of women etc.) 
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Khanum, M., Ashraf, F., & Sahrin, H. 
(2004). A Clinical Study of 100 
Cases of Eclampsia In Rajshahi 
Medical College Hospital. The 
Journal of Teachers Association, 
17(2), 17–20. 
 Rajshahi Medical 
College Hospital  
 
October 2004—March 
2005 
 
100 cases of 
antepartum/intrapartum 
eclampsia 
Age of patient, gestational 
age, mode of delivery and 
perinatal outcome as well 
as medical complications 
were recorded for all 
participants. 
• “eclampsia is the occurrence of one or more convulsion in 
association with the syndrome of pre eclampsia” 
• 58% of patients were primigravida, 25% were  
Khatun F, Rasheed S, Moran AC, 
Alam AM, Shomik MS, Sultana M, et 
al. Causes of neonatal and 
maternal deaths in Dhaka slums: 
Implications for service delivery. 
BMC Public Health. 2012 Jan;12. 
Cross sectional Gulshan, Uttara, and 
Kamrnagir (slums), 
Dhaka 
 
January 2008-December 
2009 
 
n=576 (93 adult female, 
483 children <5) 
 
All deaths of adult females 
and children under five in 
the slums studied were 
included.  
 
Deaths were detected 
through MONOSHI 
program’s MIS system and 
an interviewer visited the 
household to conduct a 
verbal autopsy (based on 
questionnaire developed by 
INDEPTH) 
 
Causes of death were 
assigned based on 
International Classification 
of Diseases version 10 and 
“types” of death (non-
maternal, maternal, 
neonate, infant and 
children) were defined. 
• 38 of the adult female deaths were “maternal” and 260 of the 483 
child deaths were “neonates” 
• Maternal death = “any death of a woman (aged 15-49) while 
pregnant or within 42 days of delivery or termination of pregnancy, 
irrespective of the duration and site of the pregnancy, from any 
cause related to or aggravated by the pregnancy or its 
management, but not from accidental or incidental causes.” 
• Neonatal death = “death of newborn within 28 days of birth due to 
any cause.” 
• 47% of neonates were low birthweight (<2500 g) and 52% were 
pre-term (<37 weeks) 
• 16% of maternal deaths were due to eclampsia (second most 
common cause in study) 
 
Khatun K, Ara R, Aleem NT, Khan S, 
Husein S, Alam S, et al. Maternal 
mortality in obstetrics and 
gynaecology in a tertiary care 
hospital. Mymensingh Med J. 
Bangladesh; 2015 Jan;24(1):103–
7. 
Cross sectional Dhaka Medical College 
Hospital, 
 
July 2003-June 2004 
 
98 maternal deaths  
 • Hypertensive disorders of pregnancy were the most common cause 
of maternal death (41.84%)  
• 36 (36.7%) of the patients died from eclampsia and 5 (5.1%) died 
with pre-eclampsia. 
• Maternal death incidence = 18.5/1000 live births 
• Secondary causes of death included 3 cases (3.1%) of HELLP 
syndrome.  
• This study showed that “Eclampsia is the leading cause of 
pregnancy related death”  
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Rahman MH, Akhter HH, 
Chowdhury M, Yusuf HR, Rochat 
RW. Obstetric deaths in 
Bangladesh, 1996-1997. Int J 
Gynecol Obstet. 2002 
May;77(2):161–9. 
Hospital record 
review and 
cross sectional 
interviews with 
clinic workers 
and field 
workers. 
Bangladesh 
 
October 1996-March 
1997 
 
28,998 deaths of 
women aged 10-50 
 
8562 maternal deaths 
Case-finding approach to 
identify deaths among 
women 10-50 years old. 
Medical records were 
reviewed and health 
service providers at 4,751 
facilities in Bangladesh that 
provide obstetric, maternal 
and child health or family 
planning services. Four 
people were interviewed at 
each facility, a principal and 
three secondary 
informants.  
• 7086 (82.8%) of maternal deaths were due to obstetric causes 
(excluding abortion). 
• 5831 (82.3%) of the obstetric deaths were classified as direct 
causes and were more likely to occur at government hospitals and 
were slightly younger, with a lower average number of children and 
were more likely to live in urban areas. 
• Causes of direct obstetric death were: eclampsia (34.3%) 
hemorrhage (27.9%) and obstructed and/or prolonged labor 
(11.3%). 
• “Eclampsia was the most frequent cause of obstetric deaths in all 
divisions except Chittagong, where hemorrhage was marginally 
more common as a cause.” 
Sayeed MA, Mahtab H, Khanam PA, 
Begum R, Banu A, Khan AKA. 
Diabetes and hypertension in 
pregnancy in a rural community of 
Bangladesh: A population-based 
study. Diabet Med [Internet]. 
2005;22(9):1267–71. 
Cross sectional 
study  
10 villages from Nandail 
sub-district.  
 
147 pregnant women of 
24-28 weeks gestation 
Married women were 
interviewed following a 
population census to detect 
pregnancy, among 
pregnant women, only 
those 24-28 weeks 
pregnant were included. 
 
Participants gave 
obstetrical history and 
underwent clinical exams. 
BP, fasting (FBG) and 2h 
blood glucose were 
assessed. 
• Prevalence of systolic hypertension (based on WHO diagnostic 
criteria) was 6.8% and diastolic 5.4% 
• Hypertension = systolic blood pressure > 140 mmHg, diastolic 
blood pressure > 90 mmHg.  
Sikder SS, Labrique AB, Ullah B, Ali 
H, Rashid M, Mehra S, et al. 
Accounts of severe acute obstetric 
complications in Rural Bangladesh. 
BMC Pregnancy Childbirth. 2011 
Oct;11. 
Nested 
qualitative 
study 
Gaibandha District 
 
October 2009-
November 2009 
 
40 women reporting 
severe obstetric 
complications  
40  women reporting one of 
the five most common 
severe obstetric 
complications were 
purposively selected to be 
interviewed 
• Eclampsia: “Convulsions, excluding epilepsy [whole body swelling 
OR severe dizziness] AND NO high fever.” 
• Accounts from women presenting with symptoms of eclampsia: 
• 30-year-old woman: reported attempting birth at home because 
childbirth is shameful 
• 16-year-old: said that no one wants a caesarian section and it is 
better to deliver at home 
• 32-year-old woman: reported perceived weakness of those who go 
to the clinic to deliver. 
• 19-year-old: reported that the village doctor was not able to handle 
her condition and told her to go to hospital. 
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TASNIM S, KABIR N, RAHMAN A, 
AHMED A, CHOWDHURY S. 
Maternal Death Audit : Experience 
from a Periurban Hospital. J 
Bangladesh Coll Physicians Surg. 
2006;24(1). 
Case record 
review 
Institute of Child and 
Mother Health, Dhaka 
 
September 1999-
December 2004 
 
13,137 live births 
 • 40 maternal deaths were found making MMR = 282 per 100,000 
live births. 
• Primary obstetric cause of death was severe PE/E (42.5%) 
 
Yousuf NA, Yousuf IA, Talukder NU, 
Kutubi A, Akhter P, Nahar S, et al. 
Maternal Risk Factors for Perinatal 
Mortality. Bangladesh J Obstet 
Gynaecol. 2011;26(2):86–91. 
Cross sectional Sylhet MAG Osmani 
Medical College 
 
July 2008-June 2009 
 
100 cases of perinatal 
mortality 
Data was collected from 
participants using a pre 
designed questionnaire.  
• 76% were stillbirths and 24% were early neonatal deaths 
• 9% of cases were due to eclampsia and 14 were due to pre-
eclampsia.  
• The only maternal risk factor that was obstructed labor which 
accounted for 19% of perinatal deaths.  
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Akhtar, S., Ali, T., Begum, S., & 
Ferdousi, S. (2013). Micronutrient 
Deficiency in Severe Preeclampsia. 
J Bangladesh Soc Physiol., 8(1), 
26–32. 
Cross 
sectional  
 
Case control 
 
Bangabanhu Sheikh 
Mujib Medical 
University, Shahbag, 
Dhaka 
 
July 2009—June2010 
 
30 cases mild PE 
30 cases severe PE 
30 normotensive 
controls 
This study assessed serum 
calcium, magnesium, and 
zinc levels in participants (18-
39 years old and >20 weeks 
gestation). Patients were 
examines and systolic and 
diastolic BP measured and 
were assessed for edema and 
proteinuria. 5ml of venous 
blood were taken and 
analyzed  
• PE is “the triad of hypertension to the extent of 140/90mmHg or 
more with proteinuria and with or without edema in pregnant 
women who were previously normotensive and non-proteinuric” 
• Both groups with PE (mild and severe) had significantly lower mean 
serum calcium, magnesium and zinc levels when compared to the 
normotensive controls. Severe PE group was significantly more 
likely to have hypocalcemia, hypozincemia and hypomagnesemia  
• Micronutrient deficiency seems to play a role in the pathogenesis 
of PE; routine screening and surveillance of these micronutrients at 
ANC is important to provide “nutritional replacement” when needed 
which may reduce PE incidence. 
Aktar, R., & Sidiqua, S. (2007). 
Eclampsia: Background of the 
sufferer. JCMCTA, 18(1), 6–8. 
Prospective 
cross 
sectional 
study 
Chittagong Medical 
College and Hospital 
 
March 2004—February 
2005 
 
425 patients with 
eclamptic convulsions 
Information was collected 
from the patients’ attendants 
(family members etc.) and 
analyzed. 
The study looked at: age, 
parity, residence, economic 
status, educational status, 
number of ANC, referral 
authority, interval between 
attack and hospital 
admission and distance from 
facility. 
• Incidence of eclampsia: 3.88% 
• 75% of patients were 20-25 years old, 71.5% were primigravida, 
75% were rural dwelling, 21.5% urban slum dwelling and 3.5% 
urban dwelling; 71.5% were “poor”; 48% were illiterate and 41% 
completed primary school, only 11% completed high school; 67%  
• 80% were self-referred, 12% were referred by general practitioners, 
and 8% were referred from PHC. 
• Over half (52%) were admitted more than 6 hours after attack, 
38% between 1 and 6 hours and 10% within the first hour 
• 46% traveled <20km, 32% traveled 20-30 km and 22% >30 km 
• Conclusions: awareness of importance of preventive care during 
ANC, female education and empowerment are needed to reduce 
mortality from PE/E 
Akter, S., Tarannum, R., & Kabir, 
M. (2013). Pregnancy in Overt and 
Subclinical Hypothyroidism and its 
Feto-Maternal Outcome. Medicine 
Today, 25(02), 69–71. 
Cross-
sectional 
study  
Bangabandhu Sheikh 
Mujib Medical University 
(BSMMU) 
 
6 months 
 
50 patients 
Patients were divided into two 
groups: Group I: patients with 
subclinical hypothyroidism 
and Group II: patients with 
overt hypothyroidism. Data on 
patients were collected using 
questionnaire and analyzed 
• 3.4% of patients in group I and 23.8% of patients in group II had PE 
• GDM with preeclampsia was only observed in group II 
• Complications during deliver included: 3.4% of group I patients and 
19% of group II had impending eclampsia 
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Akther, R., & Rashid, M. (2009). Is 
Low Level of Serum Ionized 
Magnesium Responsible for 
Eclampsia ? Journal of Bangladesh 
College of Physicians and 
Surgeons, 27(2). 
prospective Dhaka Medical College 
Hospital 
 
July 2003—September 
2004 
 
50 eclampsia patients 
Patients with clinical 
diagnosis of eclampsia who 
did not receive MgSO4 prior to 
admission were randomly 
selected and followed up 
every 15 minutes until they 
were transferred to another 
ward, discharged or died. 
Patients received 4g IV 
loading dose of MgSO4 
delivered over 10-15 
minutes, followed by 3g IM in 
each buttock.  
Blood samples were taken 
before and 24 hours after 
administration of the loading 
dose.  
• This study used the MgSO4 that was “found to be effective for 
Bangladeshi women in a well designed study”5 
• 48% <20 years old, 42% were 21-30 years old; 72% were 
primigravida, 72% had no ANC, only 28% had ‘regular’ ANC 
• 68% had antepartum eclampsia, 16% intrapartum, and 16% 
postpartum 
• 90% earn <3500 taka/month 
• 10% had no albuminuria, 12% had one plus, 38% had two plus, 
and 40% had three plus. 
• Mean serum level before MgSO4 is 0.47(0.15-1.04) mmol/l and is 
significantly higher (p.001) 24 hours after the loading dose 
0.74(0.20-2.0) mmol/L 
• Conclusions: eclampsia is related to malnutrition and poverty and 
occurrence of eclamptic fits is associated with low levels of ionized 
magnesium. 
Basher, K., & Deb, K. (2006). 
Alteration in iron status in pre 
eclampsia. Mymensingh Medical 
Journal : MMJ, 15(1), 22–24. 
Cross-
sectional 
case control 
Mymensingh Medical 
College Hospital 
 
July 2003—June 2004 
 
82 women in last half of 
pregnancy, 17-40 years 
old 
Group I—32 controls 
Group II—50 cases of PE 
 
Complete obstetric history 
and obstetric and systemic 
exam performed. Blood 
samples were taken and 
analyzed for serum level of 
iron. 
• Control group had mean serum iron concentration of 63.59 + 
13.93 which is significantly lower (p<0.0010 than the case group 
of 101.30 + 18.68 
• Alteration in serum iron status in Bangladeshi women with PE is 
similar as other studies for western women and may be used as a 
diagnostic aid. 
Begum, Z., Ara, I., Tanira, S., & 
Keya, K. (2014). THE ASSOCIATION 
BETWEEN SERUM BETA- HUMAN 
CHORIONIC GONADOTROPIN AND 
PREECLAMPSIA. J. Dhaka Med 
Coll., 23(1), 89–93. 
Case control Dhaka Medical College 
Hospital 
 
January—July 2013 
 
Controls: 76 
normotensive patients  
 
Cases: 74 pregnant 
women with PE 
Serum levels of serum beta-
human chorionic 
gonadotropin were assessed 
in all participants and were 
compared between cases and 
control as well as between 
mild and severe PE cases. 
• Severe PE: >160/110 mmHg and proteinuria >5g in 24 hours as 
well as “any pregnant women with oliguria (urine output <30ml per 
hour), cerebral or visual disturbance, epigastric pain, pulmonary 
oedema or abnormal platelet count or liver function profile” was 
considered to have severe PE 
• Mean serum beta-human chorionic gonadotropin was significantly 
higher among cases than controls, and the levels were significantly 
higher among severe PE cases compared to mild PE cases. 
• There was a “significant linear correlation” with sBP and dBP 
• Rise in serum levels of beta-human chorionic gonadotropin 
correlates with the severity of PE 
• Measuring beta-human chorionic gonadotropin level may allow for 
early diagnosis and indicate severity of disease. 
Chakraborty, N., Islam, M. A., 
Chowdhury, R. I., & Bari, W. 
(2003). Analysis of ante-partum 
maternal morbidity in rural 
Cross 
sectional and 
prospective 
cohort 
Bangladesh Institute of 
Research for Promotion 
of Essential and 
Reproductive Health 
This study looked at risk 
factors leading to four 
common causes of maternal 
morbidity: antepartum 
• This study found that the risk of fits/convulsions increases with 
age. 
• Edema was also found to be higher older age groups. 
                                                          
 
 
5 The study cited, “N. Sultana, A. Begum, K. Begum,. A comparative study of loading dose of magnesium sulphate versus intra muscular injection of magnesium sulphate in eclamptic patient—J. Bangladesh College 
of Phys Surg 2003; 21: 63-68.” was not identified through this review nor did a targeted online search reveal the citation or article; the authors published a similar paper in 2013 that was based on date collected in 
2007-2008 and was captured and reviewed in this systematic review. 
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Bangladesh. The Australian 
Journal of Rural Health, 11(1), 22–
27. 
Technologies 
(BIRPERHT) 
 
November 1992—
December 1993 
 
993 pregnant women 
 
 
haemorrhage, excessive 
vomiting, fits/convulsion and 
edema. 
 
Data was collected on 
maternal morbidity using a 
multistage random sampling. 
Pregnant women from 
selected cites who were less 
than six months were 
included in the prospective 
component.  
• These results are not representative as the number of cases was 
small  
Fatima, N., Islam, F., Noor, L., Das, 
S. R., Zeba, D., & Zesmin, F. 
(2013). Serum Ferritin in 
Preeclampsia and Eclampsia : A 
Case Control Study. Faridpur Med. 
Coll. J., 8(1), 18–21. 
Case control 
study 
Dhaka Medical College 
and Hospital  
 
January 2010—
December 2010 
 
100 pregnant women, 
50 with PE/E and 50 
normotensive pregnant 
women 
Patients with anemia, and 
other pre-existing conditions 
were excluded. 
 
Blood samples were taken 
from participants and serum 
ferritin levels were analyzed 
at BSMMU.  
• PE is “a multi-system disorder of unknown etiology characterized by 
new onset of elevated blood pressure & proteinuria after 20 weeks 
of gestation.” 
• The two groups were comparable in age, gestational age, parity, 
educational status and socioeconomic status. 
• Normal range of serum ferritin is 22-120 micrograms/L; out of the 
50 cases of PE/E, ferritin level was raised in 20% (n=10) and 100% 
of controls were within normal range. 
• Mean serum ferritin level in cases (100.03 +123.52 micrograms/L) 
was significantly higher than in controls (31.53 + 20.86) 
• Serum ferritin may “play a role in the pathogenesis of preeclampsia 
and eclampsia” 
Ferdausi, M., Khatun, M., Ma, Y., 
Rahman, A., & Rahman, Z. (2013). 
Association between High Serum 
Homocystine and Preeclampsia. 
Journal of Shaheed Suhrawardy 
Medical College, 5(1), 21–25. 
Case control 
study 
Sir Salimullah Medical 
College & Mitford 
Hospital, Dhaka 
 
July 2004—June 2006 
 
100 pregnant women; 
50 cases of PE and 50 
normotensive controls 
Fasting serum total 
homocysteine concentration 
was estimated for all 
participants along with 
urinary total protein, fasting 
blood sugar, and serum 
creatinine. 
• Mild PE: BP >140/90 mmHg or <160/110 mmHg and proteinuria 
with > 0.3g/24h urine 
• Severe PE: BP >160/110 mmHg and proteinuria >2g/24 hours. 
• Mean height was found to be different among the groups: mild PE 
(158.4+2.8cm), severe PE (156.2+3.4 cm) and without PE (156.4 
+2.7) (p=0.01) 
• Heavier women with high BMI were also found to suffer more from 
PE than lighter women with lower BMI.  
• There were no significant differences observed between: fasting 
blood sugar, uric acid, and serum creatinine. 
• Mean serum homocysteine concentration in severe PE patients was 
11.5 + 4.58 mol/L, in mild PE: 10.43+5.12 mol/L and 5.70 + 1.37 
mol/L in the group without PE. 
 
Ferdous, J., Ahmed,  a., Dasgupta, 
S. K., Jahan, M., Huda, F. a., 
Ronsmans, C., … Chowdhury, M. E. 
(2012). Occurrence and 
determinants of postpartum 
maternal morbidities and 
disabilities among women in 
Matlab, Bangladesh. Journal of 
Health, Population and Nutrition, 
30(2), 143–158. 
Cross 
sectional 
hospital 
record review 
Matlab field site, icddr,b 
 
2007-2008 
 
1,162 women 
 • Hypertension was the second most common morbidity diagnosed 
6-9 weeks postpartum in 8% of the women in the “acute obstetric 
complication” group. 
• Women who had complicated births were more likely to suffer from 
hypertension; adjusted odds ratio = 3.44 CI 1.12-10.36 
• Older women (aged > 30 years) and women with high BMI (>25) 
were more likely to be hypertensive 
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Firoz, T., Sanghvi, H., Merialdi, M., 
& von Dadelszen, P. (2011). Pre-
eclampsia in low and middle 
income countries. Best Practice & 
Research. Clinical Obstetrics & 
Gynaecology, 25(4), 537–48. 
DNA Low- and middle-income 
countries  
DNA • Pre-eclampsia and eclampsia are leading causes of maternal and 
perinatal morbidity and mortality in LMIC.  
• The exact prevalence is unknown and there is significant variation 
in the prevalence of pre-eclampsia and eclamspia between 
countries. 
 
Haque, M. M., Moghal, M. M. R., 
Sarwar, M. S., Anonna, S. N., Akter, 
M., Karmakar, P., … Islam, M. S. 
(2016). Low serum selenium 
concentration is associated with 
preeclampsia in pregnant women 
from Bangladesh. Journal of Trace 
Elements in Medicine and Biology, 
33, 21–25. 
Case control 
study 
Noakhali Medical 
College Hospital 
 
June 2013—January 
2014 
 
74 cases PE 
118 normotensive 
pregnant controls 
After diagnosis of PE, detailed 
patient history was taken 
using a structured 
questionnaire, blood samples 
were taken and blood serum 
extracted then analyzed for 
selenium concentration 
• Mild PE= “patients with blood pressure 140/90 mmHg or higher 
on 2 occasions at least 6h apart” 
• Severe PE: “blood pressure 160/110 mmHg or higher on two 
occasions at least 6h apart” 
• 52 cases were mild PE; 22 were severe PE  
• Most of the PE patients were from rural areas 
• Mean selenium concentration was significantly lower in the cases 
than in controls; and mean concentration was lower among 
severe PE cases than mild PE cases. 
• Recommend further studies with selenium supplementation. 
Hoque, M. M., Bulbul, T., Mahal, 
M., Islam, N.-A.-F., & Ferdausi, M. 
(2008). Serum homocysteine in 
pre-eclampsia and eclampsia. 
Bangladesh Medical Research 
Council Bulletin, 34(1), 16–20. 
Case control 
study 
Bangabandhu Sheikh 
Mujib Medical University 
 
January 2005—
December 2006 
 
Group I: 136 
normotensive pregnant 
controls 
Group II: 84 pregnant 
women with PE 
Group III: 120 pregnant 
women with eclampsia  
Blood samples were collected 
from participants and 
analyzed for serum 
homocysteine level 
• PE “pregnancy with gestational age >20 weeks, systolic blood 
pressure >140 mmHg, diastolic blood pressure >90 mmHg 
recorded on two separate occasions 6 hours apart and 24h urinary 
protein >300mg 
• Mean homocysteine concentration in controls = 6.86 +2.47 
μmol/L; Group II (PE) = 9.54 + 3.21 μmol/L; Group III (E) = 10.57 + 
3.39 μmol/L 
• Elevated homocysteine level is associated with PE/E and there is a 
slight association with increased level and increased severity of 
PE/E 
• Suggests: routine measurement of homocysteine level and 
potential B-vitamin supplementation 
Hosna, A. U., Bhuiyan, A. K. M. M., 
Ahmed, K., Siddique, A., Salman, 
M., Begum, S. R., … Ahsan, R. 
(2008). Effects of hyperuricemia 
on perinatal outcome in 
hypertensive disorder. University 
Heart Journal, 4(2), 36–40. 
Cross 
sectional 
case control  
Dhaka Medical College 
and Hospital (DMCH) 
Bangabandhu Sheikh 
Mujib Medical University 
(BSMMU) 
 
July 2007—June 2008 
 
100 cases with HDP 
(PE/E and chronic 
hypertension) 
 
100 normal pregnancy 
controls 
Blood samples were taken 
from all participants and 
serum uric acid levels were 
determined. 
• This study found that serum uric acid was significantly higher in 
cases of PE compared to controls; serum uric acid level increased 
as severity increased (chronic hypertension, preeclampsia, 
eclampsia) 
• Out of 100 cases, there were 20 negative perinatal outcomes 
(preterm birth, stillbirth, intrauterine death) 
• Mean birthweight in infants born to PE (2.31kg) /E (2.30kg) cases 
was reduced compared to babies born to women with chronic 
hypertension (2.5kg) 
• This study claims that serum uric acid is “a better indicator of the 
fetal consequences of preeclampsia than the measurement of 
blood pressure itself” and should be performed between 24 and 
32 weeks gestation 
Islam, N. A. F., Chowdhury, M. A. 
R., Kibria, G. M., & Akhter, S. 
(2010). Study Of Serum Lipid 
Profile In Pre-Eclampsia And 
Eclampsia. Faridpur Med Coll J, 
5(2), 56–59. 
Case control 
study 
M.A.G. Osmani Medical 
College, Sylhet 
 
July 2005—June 2006 
 
100 subjects 
--40 normotensive 
pregnant women 
--60 women diagnosed 
with PE/E 
Participants were 15-45 years 
old and 24—term gestational 
age. Serum lipid profile (total 
lipids, cholesterol, 
triglycerides, HDL-cholesterol 
and LDL-cholesterol) were 
measured and monitored for 
all participants 
• PE was associated with a significant rise in triglyceride and 
reduction in HDL cholesterol concentration 
• Eclamptic women had significantly lower HDL cholesterol and 
increase in LDL cholesterol compared to normotensive pregnant 
women 
• These findings could be useful in understanding pathogenesis of 
PE/E and help develop strategies for early diagnosis or prevention. 
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Jafrin, W., Mia, A. R., Chakraborty, 
P. K., Hoque, M. R., Paul, U. K., 
Shaha, K. R., … Roy, A. S. (2014). 
An evaluation of serum 
magnesium status in pre-
eclampsia compared to the normal 
pregnancy. Mymensingh Medical 
Journal : MMJ, 23(4), 649–653. 
Case control 
study 
 
Mymensingh Medical 
College 
 
July 2009—June2010 
 
108 pregnant subjects 
--42 normotensive 
pregnant women 
--66 cases of PE (32 
severe PE) 
Participants were 28 weeks 
to term. Patients were 
classified into two groups: 
cases and controls; the cases 
were3 futher divided into two 
groups: group A had mild PE 
and group B had severe PE. 
Samples and other 
demographic and clinical 
data were collected from all 
participants and serum 
magnesium levels were 
measured 
• Mild PE “blood pressure of at least 140/90 mmHg measured on 
two occasions each 6 hours apart, accompanied by proteinuria of 
at least 300 mg per 24 hours, or at least 1+ on dipstick test” 
• Severe PE “one or more of the following criteria: blood pressure of 
at least 160/110 mmHg measured on two occasions each 6 hours 
apart, proteinuria of at least 5g per 24 hours or at least 3+ on 
dipstick testing, oliguria of lesser than 500 ml per 24 hours, 
cerebral or visual disturbances, pulmonary edema cyanosis, 
epigastric or right upper quadrant pain, impaired liver function, 
thrombocytopenia, fetal growth restriction” 
• Mean serum level in controls was 1.91+0.08 and for cases mean 
serum was 1.78+0.11  
• Within cases, serum magnesium levels were significantly lower 
among severe PE compared to mild PE  
Jafrin, W., Paul, S. K., Sultana, S., 
Rabeya, S., Hoque, M. R., & 
Muttalib, M. A. (2013). Serum 
calcium level among normal 
pregnant and pre-eclamptic 
women in a sub urban area of 
Bangladesh. Mymensingh Medical 
Journal : MMJ, 22(3), 418–422. 
 
Case control 
study 
Mymensingh Medical 
College 
 
July 2009—June2010 
 
72 subjects; 42 
normotensive and 32 
with PE 
Dara were collected from 
participants fitting inclusion 
criteria. Patients were 
clinically examined and 
interviewed for socio-
demographic information. 
Blood samples were taken 
and analyzed for serum 
calcium, serum uric acid,, 
serum creatinine levels  
• Mean serum calcium in normal pregnant women was 7.62 + 
0.24mg/dl  and was significantly lower in patients with PE 
7.32+0/28 mg/dl (P<0.001) 
• Suggests a larger study to further explore alteration in serum 
calcium levels in pre-eclamptic women 
Jahan, K., Parvin, M., & Mafiz, A. I. 
(2011). Studies on Haemoglobin , 
Serum Calcium and Ascorbic Acid 
Level in Normal Pregnant , Pre-
Eclamptic and Eclamptic Patients. 
Bangladesh Journal of Nutrition, 
24-25, 7–14. 
Case control 
study 
Dhaka Medical College 
Hospital and Sir 
Solilmullah Medical 
College Hospital 
 
52 normal pregnant 
women 
 
52 women with PE/E 
(26 with PE and 26 with 
eclampsia) 
Anthropometric data was 
collected as well as blood 
pressure and socio-economic 
data from each participant 
 
Estimations were made for 
haemoglobin (Hb) level, 
serum calcium, and serum of 
ascorbic acid 
• Toxaemia of pregnancy: PE = “a rise in diastolic blood pressure to 
90 mm of mercury or higher after 24th week of pregnancy, without 
proteinuria (mild pre-eclampsia) or with definite proteinuria not 
attributable to infection (severe pre-eclampsia) 
• This study suggests that serum calcium, serum ascorbic acid, blood 
Hb, family income, age parity may affect nutritional status of PE/E 
patients. 
Jesmin, S., Jahan, S., Khan, M., 
Sultana, N., Jerin, J., Habib, S., & 
Paul, D. (2011). The Incidence, 
Predisposing Factors, 
Complications and Outcome of 
Preeclampsia in Diabetic 
Pregnancy. Bioderm Medical 
Journal, 1(1), 10–14. 
Case control 
study 
Bangladesh Institute of 
Research and 
Rebabilitation in 
Diabetes and Endocrine 
and Metabolic 
Disorders, Dhaka 
 
80 diabetic pregnant 
women admitted 
50 cases (with PE) and 20 
controls 
 
All patients had diabetes 
 
• The incidence of PE in diabetic pregnancy is approximately 10-15%  
• Cases of PE “patients with increased systolic blood pressure of > 
30 mmHg or diastolic > 15 mmHg over a baseline blood pressure 
after 20 weeks gestation, blood pressure of > 140/90 mmHg at 
least on two measurements taken 6 hours apart after 20 weeks of 
pregnancy if prior blood pressure is not known” who had either 
preconception diabetes or gestational diabetes. 
• The study group was more likely to experience CS, preterm birth, 
low birth weight,  
Khan, A. E., Scheelbeek, P. F. D., 
Shilpi, A. B., Chan, Q., Mojumder, 
S. K., Rahman, A., … Vineis, P. 
(2014). Salinity in Drinking Water 
and the Risk of (Pre)Eclampsia 
Case control 
study 
Upazilla Health 
Complex, Dacope 
 
October 2009—April 
2011 
Data collected from 
participants included: 
information on drinking water 
sources, previous 
pregnancies, socioeconomic 
• PE: “raised BP of > 140/90 mmHg and significant proteinuria (0.3 
grams on at least two random clean catch urine samples) with or 
without pathological oedema occurring after the 20th week of 
pregnancy, in a previously normotensive and non-proteinuric 
patient” 
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and Gestational Hypertension in 
Coastal Bangladesh: A Case-
Control Study. PLOS ONE, 9(9). 
 
202 cases 
1,006 controls 
conditions, occupation, 
lifestyle, diet, and medical 
history  
 
Water samples were taken at 
time of interview and sent for 
analysis of sodium levels.  
• Eclampsia= “pre-eclampsia complicated with convulsions that 
could not be attributed to other causes and/or coma 
• Water samples were only taken for 202 cases and 553 controls. 
• 162 cases of PE, 33 cases of gestational hypertension and 7 cases 
of eclampsia 
• Mean water sodium levels were higher in the cases (728 mg/L) 
compared to the controls (440 mg/L); this difference was 
significant 
• Tube-well water had highest sodium levels (714 mg/L) with filtered 
pond and pond water following.  
• High BP levels were found in women drinking from water sources 
with higher salinity 
• Salinity in drinking water is associated with increased risk of PE/E 
and gestational hypertension in this population. 
Khanam, M., & Ilias, M. (2013). 
Study of Thyroid Hormonal Status 
in Preeclamptic Patients. Medicine 
Today, 25(2), 63–66. 
Case-control 
study 
Chattagong Medical 
College Hospital 
 
January 2005—
December 2005 
 
52 consecutive cases of 
PE in 3rd trimester 
 
52 healthy pregnant 
women in 3rd trimester. 
Blood samples were collected 
from all participants and 
serum separated and stored. 
Free T3, free T4, and TSH 
(thyroid-stimulating hormone) 
were measured and all 
women were followed up 
throughout pregnancy and 
postpartum especially for 
signs of hypothyroidism. 
• This study found that mean TSH was significantly higher in the 
study group (4.14+2.24 mIU/L) compared to the control group 
(2.75+1.73 mIU/L) 
• There was no significant difference between T3 or T4 levels in the 
two groups 
• TSH level could have predictive value for development of PE in 
pregnancy; further research is needed with larger sample size. 
Khatun, A., Kirtania, K., Shima, T. 
S., Ferdousi, S., Shahnaz, A., 
Yeasmin, F., & Sultana, N. (2010). 
Association of Serum Calcium and 
24 Hours Urinary Excretion of 
Calcium in Patients of 
Preeclampsia. Bangladesh J Med 
Biochem, 3(2), 57–60. 
 
Case control 
study 
Department of 
Biochemistry, Dhaka 
Medical College (DMC),  
 
July 2008-June 2009 
 
60 cases 
30 age-matched 
controls with 
uncomplicated 
pregnancy 
Levels of serum total calcium, 
total protein, albumin and 
globulin, and excretion of 
urinary calcium in control  
were measured in all 
participants and compared by 
study group 
• Mean measured serum calcium levels were highly significantly 
different between cases (1.96 + 0.17) and controls (2.34 + 0.12). 
The adjusted serum calcium level was also significantly different 
between groups. 
• In addition, a highly significant difference in urinary calcium 
excretion levels between groups: case = 94.40 + 10.68 mg/24hr 
and control= 154.35 + 66.68 mg/24hr. 
• Cases were significantly more likely to have hypocalciuria (70%) 
compared to controls (20%) 
• Hypocalcaemia and hypocalciuruia may be useful measurements 
for distinguishing PE from other forms of gestational hypertension. 
Khatun S, Kanayama N, Belayet 
HM, Bhuiyan AB, Jahan S, Begum 
A, et al. Increased concentrations 
of plasma neuropeptide Y in 
patients with eclampsia and 
preeclampsia. Am J Obstet Gynecol 
[Internet]. 2000 Apr;182(4):896–
900. 
Case control 
study 
Dhaka Medical College 
Hospital, Bangladesh 
 
Jan 1996—March 1998 
 
Patients in 3rd trimester 
admitted with untreated 
eclampsia (n=8), 
preeclampsia (n=8) and 
normotensive pregnancy 
(n=8) and non pregnant 
healthy volunteers (n=8) 
Midstream urine collection 
and blood samples were done 
in the morning for all 
participants who did not have 
eclampsia. Samples were 
taken from eclampsia patient 
during admission (none had 
already received 
antihypertensives or 
anticonvulsants prior to 
sample collection). 
 
Samples were taken again 6 
days after delivery 
 
Plasma neuropeptide Y 
concentration was measured 
• Eclampsia “> 1 episode tonoclonic seizure in the presence of other 
evidence of preeclampsia and the absence of either a history of a 
seizure disorder or evidence for another cause, such as trauma or 
infection.” 
• Preeclampsia: “a blood pressure > 140/90 mm Hg on two 
occasions > 6 hours apart or a rise of >30 mmHg systolic or >15 
diastolic above baseline blood pressure with proteinuria of >300 
mg/24 h.” 
• Plasma neuropeptide Y concentration levels were four times higher 
in eclampsia cases and two times higher in pre eclampsia cases 
than in normal pregnancy controls. 
• These levels were significantly decreased in samples taken 6 days 
post delivery,  
• There were no significant correlations found between neuropeptide 
Y concentration and MAP for any of the groups in either sampling. 
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in blood and urine was 
assessed for protein levels. 
 
Statistical analyses were 
conducted to compare the 
study groups  
• “Increased plasma neuropeptide Y concentrations may plan a key 
role in the development of clinical features of eclampsia and pre-
eclampsia.” 
Mahal M, Ms H, Sultana N, Ns C, 
Sakmn A, Hossain M, et al. STUDY 
OF ELEVATION OF SERUM 
HOMOCYSTEINE LEVEL IN 
ECLAMPSIA IN A SPECILIZED 
HOSPITAL SETTING IN 
BANGLADESH. J Dhaka Med Coll 
[Internet]. 2010 [cited 2015 Jun 
5];19(2):131–4. 
Case control 
study 
Dhaka Medical College 
Hospital 
 
July 2006-June 2007 
 
50 cases of eclampsia 
52 healthy pregnant 
women 
 
Participants were matched 
based on maternal age, 
gestational age and BMI. 
 
Blood samples were taken 
from all participants and 
serum homocysteine 
concentration was analyzed 
and the data compared 
between groups. 
• Both mean systolic and diastolic levels were significantly higher for 
the cases (150+14.22/104+8.92 mmHg) when compared to 
controls (113.27 + 11.37/). 
• Mean serum homocysteine concentration among cases was 10.44 
+ 4.08 µmol/L, which was significantly higher than mean in control 
group (7.97 + 3.46) 
• This study found that serum homocysteine levels are elevated in 
women with eclampsia and can be used to detect eclampsia in 
pregnant women. 
• The authors suggest that B12 and B6 vitamin and folic acid 
supplementation could play a role in preventing increase in 
homocysteine in pregnant women.  
Mahal M, Yeasmin F, Sakmn A, 
Shahnaj A, Rashid M, Ms H. 
Association of Serum 
Homocysteine and Serum Lipid 
With Eclampsia. JAFMC 
Bangladesh. 2009;5(1):9–12. 
Case control 
study 
Dhaka Medical College 
Hospital 
 
July 2006-June 2007 
 
50 cases of eclampsia 
52 healthy pregnant 
women 
 
Participants were matched 
based on maternal age, 
gestational age and BMI. 
 
Blood samples were taken 
from all participants and 
serum homocysteine, serum 
cholesterol, triacylglycerol, 
LDL cholesterol, and HDL 
cholesterol levels were 
analyzed and the data 
compared between groups. 
• This paper is based on the same study as the Mahal et al., 2010 
paper, above. 
• Serum cholesterol, triacylglycerol and LDL-cholesterol were not 
significantly different between the study groups  
• A significant negative correlation was found between homocysteine 
and HDL cholesterol for cases of eclampsia  
• Conclusion: increased homocysteine level and “isolated HDL-C 
deficiency are associated with eclampsia.” 
Manna FN, Khanam NN, 
Chowdhury KA, Das SN, Kabir MA, 
Zubyra SJ, et al. Study on 
Association of Maternal Serum 
Triglyceride with Pre-eclampsia. 
Mymensingh Med J. Bangladesh; 
2015 Jul;24(3):578–84. 
Case control 
study 
Bangabandhu Sheikh 
Mujib Medical University 
Hospital and Dhaka 
Medical College Hospital  
 
January 2006-
December 2007 
 
45 patients with PE 
45 normal healthy 
pregnant women 
After overnight fasting, 
participants gave a blood 
sample and triglyceride levels 
were measured. Medical 
history and clinical 
examination were done and 
all results analyzed.  
• The patients with PE had statistically higher systolic and diastolic 
BP (152.4 + 19.8/ 103.1 +12.2 mmHg)) compared to the controls 
(112.0+8.9/75.5+6.6 mmHg). 
• Mean serum triglyceride level was 242.9+36.8 mg/dl in PE group, 
which is significantly higher than the control group mean of 
184.6+12.5 mg/dl.  
• Serum triglyceride level correlated with severity of urine albumin.  
• Since “the level of serum triglyceride correlates with the severity of 
pre-eclampsia. So, serum triglyceride level estimation in pregnancy 
may be used as an indicator of pre-eclampsia.” 
Mannan M, Rahman M, Ara I, Afroz 
H. Prevalence and pregnancy 
outcome of gestational diabetes 
mellitus among Bangladeshi urban 
pregnant women. J Med [Internet]. 
2012;13(2):147–51. 
Descriptive, 
cross 
sectional, 
followed by 
cohort study 
Sir Salimullah Medical 
College Hospital, 
Azimpur Maternity 
Center and some 
selected private 
hospitals in Dhaka city. 
 
July 2006-June 2007 
All pregnant women at the 
facilities were screened for 
Gestational Diabetes Mellitus 
(GDM). For each woman 
found to have GDM, one non-
GDM pregnant woman was 
age and parity matched as a 
control. 
• Maternal outcomes included: antepartum haemorrhage, 
polyhydramnios, pre-eclampsia, postpartum haemorrhage, urinary 
tract infection, postpartum haemorrhage, eclampsia, surgical 
intervention, puerperal sepsis, and mortality. 
• Neonatal outcomes included: prematurity, postmaturity, low birth 
weight, large baby, still birth, macrosomia, congenital 
malformations, neonatal jaundice, respiratory distress syndrome 
and mortality.  
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960 pregnant women, 
24-28 weeks pregnant 
 
Participants were followed up 
to 4 weeks “early neonatal 
period” and maternal and 
neonatal outcomes were 
recorded  
• Prevalence of GDM in 906 women 7.5% 
• Pre-eclampsia was more prevalent in the GDM group (25%) 
compared to controls (1.4%) 
• Prevalence of eclampsia did not differ between the groups (2.8% in 
GDM cases, and 1.4% in controls). 
Mondal B, Ahmed S, Saha S, 
Parveen S, Paul D, Sultana T, et al. 
Alanine Aminotransferase and 
Total Bilirubin Concentration in 
Preeclampsia and Eclampsia. 
Mymensingh Med J. 
2016;25(1):85–90. 
Cross-
sectional 
comparative 
study 
Bangabandhu Sheikh 
Mujib Medical University 
and Dhaka Medical 
College Hospital.  
 
March 2012-February 
2013 
 
150 women > 28 weeks 
pregnant; 50 with PE, 
50 with eclampsia and 
50 healthy controls.  
Full medical history, complete 
obstetric history and clinical 
data were collected for all 
participants. Venous blood 
samples were then taken 
from all participants and 
analyzed for serum total 
bilirubin and Alanine 
Aminotransferase (ALT) 
concentrations 
• Mean serum total bilirubin and ALT were found to be significantly 
higher in PE/E groups compared to normal pregnancy group, 
however there was no significant differences in levels between the 
PE group and the eclampsia group 
•  
Nahar K, Yasmin H, Shamsuddin L. 
Serum Magnesium in Pre-
eclampsia and Eclampsia. 
Bangladesh J Obstet Gynaecol. 
2010;25(1):15–9. 
Cross 
sectional 
case control 
study 
Mymensingh Medical 
College and Hospital 
 
July 2009-June 2010 
 
60 cases with PE/E and  
60 controls with 
normotensive pregnancy 
Serum magnesium was 
assessed in all participants by 
photometric test using xylidyl 
blue.  
 
Information on each 
participant was collected 
through questionnaires and 
each participant gave 5 ml 
blood samples 
• Statistical difference in ANC between the groups. 66.67% of 
controls attended regular ANC and 8% of controls.  
• Only 16.67% of controls had no ANC and 81.67% of cases had no 
ANC 
• The difference in serum magnesium levels was highly statistically 
significant between cases (1.84 + 0.26 mg/dl) and controls (2.29 
+ 0.28 mg/dl) 
• Serum magnesium was also significantly lower in eclampsia 
patients compared to Pre-eclamptic patients.  
• Conclusion: “the estimation of serum magnesium of of pregnant 
women during antenatal period should be done to detect pre-
eclampsia in high risk group and thereby to prevent eclampsia. Oral 
magnesium preparations should be supplemented during pre- 
pregnancy or early pregnancy for prevention of pre- eclampsia and 
eclampsia.” 
Rahim R, Nahar K, Khan IA. 
Platelet count in 100 cases of 
pregnancy induced hypertension. 
Mymensingh Med J. Bangladesh; 
2010 Jan;19(1):5–9. 
Prospective 
study 
Mymensingh Medical 
College Hospital 
(MMCH) 
 
January –July 2006 
 
100 cases (60 
eclampsia, 34 pre-
eclampsia and 6 
gestational 
hypertension) 
Relevant data were collected 
from all participants, blood 
samples taken and analyzed. 
Participants were grouped 
based on their diagnosis 
(eclampsia, pre-eclampsia, or 
gestational hypertension) as 
well as by gestational age 
(28-31 weeks, 32-35 weeks, 
36-39 weeks, and 40 weeks 
and above) 
• 56 (93.33%) of eclampsia patients and 6 (17.65%) of PE patients 
had no ANC 
• 36 (60%) of eclampsia patients had platelet counts 150,000 
• 23 (67.65%) of PE patients and 50% of gestational hypertension 
patients had platelet counts between 150,000 and 200,000 
• Perinatal outcomes; 39% were born term/healthy, 35% were 
preterm/LBW, 18% were stillborn and 8% experienced neonatal 
death. Perinatal mortality was 26% 
• Maternal mortality for this study was 3% 
• 74.28% of patients with platelet counts <150,000 had babies 
<2500 grams.  
• Thrombocytopenia, prematurity, and perinatal mortality were 
common complications among eclampsia patients.  
Razzaque A, Da Vanzo J, Rahman 
M, Gausia K, Hale L, Khan MA, et 
al. Pregnancy spacing and 
maternal morbidity in Matlab, 
Bangladesh. Int J Gynaecol Obstet 
[Internet]. 2005 Apr [cited 2015 
Jun 4];89 Suppl 1:S41–9. 
Based on 
data from 
Matlab Study 
Matlab, Bangladesh Data on maternal morbidity 
was collected from “pictorial” 
cards given to women when 
pregnancy is identified as 
part of the maternity care 
program. Complications that 
were noted during the third 
• Pre-eclampsia = “the presence of any two of edema, protein-uria, 
[sic] or high blood pressure.” 
• Inter-pregnancy interval is defined as, “the amount of time between 
the date of the preceding outcome (live birth, stillbirth, or 
miscarriage [induced or spontaneous]) and the date of the last 
menstrual period before the index pregnancy.”  
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trimester are considered in 
this analysis. Complications 
included: proteinuria, high 
blood pressure, bleeding, 
premature rupture of 
membranes, anemia, edema, 
and pre-eclampsia. 
• Pre-eclampsia tended to be higher among those with a short inter-
pregnancy interval (under 6 months) and longer intervals (75 
months or more). 
• PE did not vary by maternal age but was significantly higher for 
women who had experienced two or more pregnancy losses. 
• This study found that the incidence of PE and proteinuria was lower 
among teenage mothers.  
Sarwar M, Ahmed S, Ullah M. 
Comparative study of serum zinc, 
copper, manganese, and iron in 
preeclamptic pregnant women. 
Biol trace Elem … [Internet]. 2013 
Case control 
study 
Noakhali Medical 
College Hospital 
 
June 2012-February 
2013 
 
50 cases of 
preeclampsia > 20 
weeks 
 
58 normotensive 
pregnant women, 
controls 
Detailed patient history was 
recorded for cases and 
controls. 5ml venous blood 
samples were taken, stored 
and processed to extract 
serum and analyzed. 
 
 
• “Preeclampsia (PE), also known as toxemia or pregnancy-induced 
hypertension is a human pregnancy-specific disorder which can be 
defined as the new onset of hypertension and significant 
proteinuria in a previously normotensive woman on or after the 
20th week of gestation with or without pathological edema” 
• Hypertension = systolic blood pressure > 140 mmHg and diastolic 
blood pressure > 90 mmHg at least on two measurements within 
6h or more. 
• Mean BP for cases was 167.8+2.54/120.34 + 1.16 mmHg 
compared to the controls: 108.2+1.86/79.66+0.96 
• Serum trace elements were statistically different between the two 
study groups 
• Mean value of Zn in cases = 0.77+0.05 mg/L and in controls = 
0.98+0.03 mg/L 
• Mean value of Cu for cases = 1.98+0.10 mg/L and in controls = 
2.58+0.06 
• Mean value of FE for cases = 1.13+0.22 mg/L and in controls = 
1.96+0.32 
• Mean value of Mn for cases = 0.08+0.02 mg/L and in controls = 
0.14+0.02 
• Preeclamptic pregnant women have low serum concentrations of 
Zn, Cu, Mn, and Fe 
Sufrin S, Nessa A, Islam M, Khatun 
A, Husain M, Khatun N, et al. 
Blood Pressure in Third Trimester 
of Pregnancy. Mymensingh Med J. 
2016;25(1):18–22. 
Cross 
sectional 
case control 
study 
 
 
Mymensingh Medical 
College 
 
July 2013-June 2014 
 
100 pregnant women in 
3rd trimester  
100 healthy non-
pregnant women 
Blood pressure was taken 
after 15 minutes rest for all 
participants. Two 
measurements were taken 5-
10 minutes apart. The 
average of the two 
measurements was recorded.  
• Hypertension: “a systolic blood pressure of 140 mm of Hg or 
greater or a diastolic blood pressure of 90 mm of Hg or greater” 
• Mean systolic BP was 124.8 + 14.51for study group and 106.5 + 
10.67for controls (non-pregnant)  
• Mean diastolic BP was 
•  83.0 + 13.37 for study group and 71.05 + 7.12 for controls.  
• “trophoblastic hypoperfusion is the earliest and most consistent 
change in pre-eclampsia and is believed to be an important cause 
of disease” 
 
Sultana R, Karim SMF, Atia F, 
Ferdousi S, Ahmed S. Platelet 
Count In Preeclampsia. J Dhaka 
Natl Med Coll Hos. 
2012;18(02):24–6. 
Case control 
study 
Dhaka Medical College 
 
July 2010-June 1022. 
 
100 pregnant women in 
3rd trimester: 50 cases 
of PE and 50 normal 
healthy pregnancies. 
1.5 ml of blood was drawn 
from each participant and 
processed for platelet count 
analysis.  
 
 
• Mean platelet count for cases = 144,260+96,472 
• Mean platelet count for controls = 198,100+51,219 
• The difference was statistically significant between the groups. 
• Low platelet count is associated with PE and could be useful in 
identifying PE  
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Sultana S, Dabee SR, Akter S, 
Akhter P. Serum C reactive Protein 
in Preeclamptic Women. J 
Bangladesh Coll Physicians Surg. 
2013;31(4):194–8. 
Case control 
study 
Bangladesh Institute of 
Research and 
Rehabilitation in 
Diabetes, Endocrine and 
Metabolic Disorders 
(BIRDEM) and Dhaka 
Medical College Hospital 
 
July 2009-June 2010 
 
60 women in 3rd 
trimester (30 
normotensive and 30 
preeclamptic) 
Controls had normal blood 
pressure throughout 
pregnancy and no proteinuria. 
 
Cases had blood pressure 
140/90mmHg on at least two 
occasions 6 hours apart, 
gestational age of 20 weeks 
and urinary protein of 0.3g/L 
or more. 
 
2ml blood drawn from all 
participants and processed to 
separate out serum which 
was analyzed for serum C 
reactive protein 
concentrations. 
• Mean C reactive protein (CRP) concentration was significantly 
higher in the case group (10.57+6.71 mg/dl) compared to controls 
(0.63+0.49 mg/dl) 
• 93.3% of cases had raised CRP and only 16.7% of controls had 
raised CRP. 
• Raised CRP level is shown to be associated with preeclampsia but 
it is not known whether it is the cause or the effect of PE 
Ullah MI, Koch CA, Tamanna S, 
Rouf S, Shamsuddin L. Vitamin D 
deficiency and the risk of 
preeclampsia and eclampsia in 
Bangladesh. Horm Metab Res. 
Germany; 2013 Sep;45(9):682–7. 
Case control Dhaka Medical College 
Hospital 
 
150 consecutive 
patients with PE/E after 
20 weeks 
 
100 consecutive normal 
pregnancies. 
Blood samples were taken 
within 48 hours of admission 
to hospital and prior to 
initiation of MgSO4. Serum 
25(OH)D levels were 
checked. 
 
Controls were recruited from 
the out-patient clinic.  
• A cutoff of a plasma 25(OH)D level of <30 ng/ml was used to 
determine maternal vitamin D insufficiency.  
• 78.19% of all participants had vitamin D insufficiency 
• 25(OH)D levels were on average, lowest among those with 
eclampsia (21.56 +1.16 ng/ml), next lowest among those with PE 
(23.96+1.31 ng/ml and highest among controls (24.86 + 1.02 
ng/ml) 
• The study found that the relationship of vitamin D deficiency and 
PE/E was not linear 
• Rates of prematurity (<36 weeks) was higher among cases of 
eclampsia (56.09%) and PE (24.39%) compared to controls 
(19.51%) 
• Conclusion: there is a high prevalence of vitamin D insufficiency in 
Bangladesh and vitamin D insufficiency is associated with a 3-5 
fold increase in risk of PE/E.  
Yesmin F, Islam M, Ferdoushi S, 
Faisal F, Rehena Z, Afroza F, et al. 
Evaluation of Serum Ferritin 
Concentration in Mild and Severe 
Pre-Eclamptic Women. 
Mymensingh Med J. 
2016;25(1):119–25. 
Case control Bangabandhu Sheikh 
Mujib Medical University 
 
March 2011-March 
2012 
 
70 pregnant patients 
28-40 weeks gestation 
during the study period. 
6 ml blood was collected from 
each participant and serum 
separated and tested for iron 
profile.  
• 40 cases of PE (20 “mild” and 20 severe) and 30 normotensive 
• Mean age of groups were not statistically significant.  
• Mean systolic BP for controls = 104.5 +7.92 mmHg, mild PE = 
144.0+8.83 mmHg, and severe PE = 164.5+7.59 mmHg 
• Mean diastolic BP for controls = 66.33+6.01 mmHg, mild PE = 
94.25 + 0.06 mmHg and severe PE = 112.75 +0.52 mmHg 
• Mean serum iron level in mild PE group = 114.45+8.72 μg/dl 
which is approximately 1.5 times higher than the mean serum iron 
level in controls (72.64+4.72 μg/dl) 
• Mean serum iron level for severe PE (174.35+13.59 μg/dl) group 
was almost 2.5 times higher than among controls  
• Mean serum ferritin concentration also differed significantly across 
groups: control = 18.47+2.03 ng/ml, mild PE = 99.91+7.84 ng/ml, 
and severe PE = 149.59+13.75 ng/ml 
• This study found higher concentrations of serum ferritin and serum 
iron is associated with mild and severe PE 
Yoshimura T, Chowdhury FA, 
Yoshimura M, Okamura H. Genetic 
and environmental contributions 
to severe preeclampsia: lack of 
association with the endothelial 
Case control 112 Bangladeshi 
women with severe PE 
and  
119 age-matched 
controls 
 • Severe PE  = “a blood pressure of > 160/110mmHg and 
proteinuria >3+.” 
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nitric oxide synthase Glu298Asp 
variant in a developing country. 
Gynecol Obstet Invest. Switzerland; 
2003;56(1):10–3. 
• This study found that the body weight of the neonates was 
significantly lower for those born to mothers with severe PE 
(2.26+0.56 kg) compared to controls (3.03+0.52 kg).  
• They found no significant difference between groups for 
frequencies of Glu298Asp variant or eNOS/T 
• Glu289Asp eNOS gene is not a good marker for increased risk of 
PE. 
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Akter S, Sultana S, Dabee SR. 
Association of 
Hyperuricaemia with Perinatal 
Outcome in Pregnancy 
Induced Hypertension. J 
Bangladesh Coll Physicians 
Surg. 2014;32 (3). 
Case-
control 
study 
Bangladesh Institute of 
Research and 
Rehabilitation (BIRDEM) 
and Dhaka Medical College 
Hospital (DMCH) 
 
“during January and 
December 2010”  
 
Group I: 60 women with 
PIH 
Group II: 60 normotensive 
women 
All participants were in their third 
trimester of pregnancy. Data on each 
patient was collected using a 
predesigned sheet and blood was 
taken from each patient for 
estimation of serum uric acid 
concentration.  
 
The dependent variables for this 
study were: preterm, stillbirth, IUGR, 
term and healthy babies.  
• Mean systolic and diastolic BP was significantly high in group I 
(150.17 + 9.26 vs. 107.73 +7.60 mmHg). 
• Mean uric acid concentration was also significantly higher in 
group I compared to group II (7.21 +1.81 mg/dl vs. 4.40 + 0.84 
mg/dl). 
• Group I: 13 (21.7%) term/healthy babies, 24 (40%) preterm, 9 
(15%) IUGR and 14 (23.3%) stillborn. 
• Group II: 53 (88.3%) term/healthy babies, 3 (5.0%) preterm, 2 
(3.3%) IUGR, and 2 (3.3%) stillborn. 
• This study showed that there is a positive statistically significant 
relationship between dBP and hyperuricaemia in patients with 
PIH (group I) 
• When serum uric acid level >6mg/dl, for group I, 86% had 
adverse perinatal outcomes (preterm, IUGR, stillbirth) and as 
serum uric acid levels increased, birth weight significantly 
decreased 
Alam, I. P., & Akhter, S. 
(2008). Perinatal Outcome of 
Eclampsia in Dhaka Medical 
College Hospital. Bangladesh 
Journal of Obstetrics & 
Gynaecology, 23(1), 20–24. 
Cross 
sectional 
Dhaka Medical College 
Hospital 
 
February 2001—July 2001 
 
300 mothers, 311 babies 
All participants were admitted in the 
eclampsia unit and stayed more than 
48 hours after delivery. Data were 
collected from patients using a 
questionnaire, ANC records, 
observation and interview with 
attendants.  
 
Hypertension was controlled with 
hydralazine and other 
antihypertensives and convulsions 
were controlled with MgSO4.  
• 42 (13.5%) of the births were fresh stillbirths, 7 (2.3%) were 
macerated intrauterine deaths.  
• Perinatal mortality was 290 per 1000 live births. 
• 75% were 15-25 years old 
• 61.3% were primiparous and 34.23% experienced perinatal 
death 
• Perinatal death was higher among those with no ANC 
Anwar, S., Chowdhury, J., 
Khatun, M., Mollah, A. H., 
Begum, H. A., Rahman, Z., & 
Nahar, N. (2006). Clinical 
profile and predisposing 
factors of cerebral palsy. 
Mymensingh Medical 
Journal : MMJ, 15(2), 142–
145. 
 Child Development & 
Neurology Care Center of 
Dhaka Medical College 
Hospital 
 
January 2002—December 
2003 
 
110 cases of cerebral 
palsy (CP) 
Socio-demographic information, 
perinatal details and developmental 
events were collected from the 
participants with CP.  
• 29.1% of the children with CP were born to mothers who had 
suffered from PE/E during pregnancy.  
Baqui, A. H., Choi, Y., 
Williams, E. K., Arifeen, S. E., 
Mannan, I., Darmstadt, G. L., 
& Black, R. E. (2011). Levels, 
timing, and etiology of 
stillbirths in Sylhet district of 
Bangladesh. BMC Pregnancy 
and Childbirth, 11, 25. 
 Three rural sub-districts of 
Sylhet district 
 
2003—2005 
 
1748 stillbirths 
Endline survey for Projahnnmo-1 
project.  
 
Verbal autopsy was performed for 
each of the stillbirths during the study 
period. 
• Maternal hypertensive disorders (pregnancy-induced 
hypertension, preeclampsia and eclampsia) were one of the five 
observed causes of antepartum and intrapartum stillbirth 
• Maternal hypertensive disorders = “convulsion OR hypertension 
during pregnancy diagnosed by a health worker 
• Preventing maternal complications that can lead to stillbirth is 
necessary 
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Bhowmik, D. K. (2013). 
Alteration of Liver Function in 
Preeclampsia and Eclampsia. 
Chattagram Maa-O-Shishu 
Hospital Medical College 
Journal, 12(3), 9–10. 
 
Case 
control 
study 
Osmani Medical College 
Hospital, Sylhet 
 
January 2012—November 
2012 
 
47 cases with PET and 
eclampsia 
 
35 normal pregnant 
women as controls 
Medical history and physical exams 
were performed for each participant, 
urine was tested for albumin, blood 
samples were taken and ALT, AST, 
serum bilirubin, serum creatinine 
were measured and results were 
analyzed between study groups. 
• 27 patients had PET and 20 had eclampsia.  
• Patients with PET and eclampsia had higher levels of proteinuria, 
ALT, AST, serum bilirubin, and alkaline phosphatase.  
• Liver function impairment is common in patients with PE/E 
Hassan, M., Begum, M., 
Haque, S. M. Z., Jahan, N., 
Yasmeen, B. H. N., Mannan, 
A., … Rahman, H. (2015). 
Immediate Outcome of 
Neonates with Maternal 
Hypertensive Disorder of 
Pregnancy at a Neonatal 
Intensive Care Unit. Northern 
International Medical College 
Journal, 6(2), 57–60. 
Prospecti
ve cohort 
study 
Ad-din Women’s Medical 
College Hospital 
 
January 1, 2012---March 
31, 2013 
 
60 neonates 
60 neonates with maternal history of 
hypertensive disorders of pregnancy. 
Neonatal parameters were collected 
including sex, gestational age, birth 
weight etc. as well as medical 
complications.  
• “gestational hypertension: hypertension manifested after 20 
weeks of gestation”; PE/pre-eclamptic toxaemia (PET): 
“hypertension associated with proteinuria greater than 0.3g in a 
twenty four hour urine collection or greater than 1g/L in a 
random sample” “essential hypertension”: “presence of 
sustained blood pressure of 140/90 mmHg or higher before 
pregnancy or before twenty weeks gestation”; PE superimposed 
on essential hypertension: PE in previously hypertensive women; 
Eclampsia: “PE when complicated with convulsion and/or coma” 
• 36 (60%) of mothers had gestational HTN, 13 (21.66%) had PET, 
5 (8.33%) had eclampsia, and 6 (10) had E after essential HTN 
• Only 16 (26.66%) of babies were delivered term, the rest were 
delivered before 36 weeks pregnancy.  
• 76.66% of newborns were low or very low birth weight (1kg to 
2.5kg) 
• Other clinical problems included: respiratory distress (50%), PNA 
with seizure (13.33%), meconium aspiration syndrome (20%), 
and neonatal thrombocytopenia/low platelet count (20%)  
• Neonates delivered to women with PE, had 50% incidence of 
neutropenia (neutrophil count less than 500). 
• There were six (10%) neonatal deaths 
Hussain, S. S., Choudhury, M. 
B. K., Akhter, J., Begum, S., 
Mowsumi, F. R., & Azad, M. K. 
H. (2011). Fetal Outcome of 
Pre-eclamptic Mothers with 
Hyperuricemia. J. Dhaka 
National Med. Coll. Hos., 
17(01), 41–43. 
Comparat
ive cross 
sectional  
Sylhet MAG Osmani 
Medical College 
 
July 2007—June 2008 
 
Group I: 25 mothers with 
PE w/hyperuricemia 
 
Group II: 32 PE mothers 
with normal serum uric 
acid level 
 
Fetal outcome markers (stillbirth and 
low birth weight (LBW)) were observed 
for all participants. Results analyzed.  
• The study groups were similar in maternal age 
• Mean blood pressure levels for group I was sBP=156.30 + 
18.60, dBP = 102.61 + 12.42 and for group II: sBP = 151.72 + 
12.09, dBP = 98.59+ 7.54 
• There was no statistically significant difference in BP levels 
between the groups 
• Group I: had 20% (n=5) normal birth weight babies, and 72% 
(n=18) low birth weight babies 
• Group IIL had 90.62% (n=29) normal birth weight and 9.38% 
(n=3) low birth weight 
• Group I: 92% live birth and Group II: 100% live birth 
• “hyperuricemia associated with PE is an important risk factor for 
poor fetal outcome”  
• The study findings show that incidence of poor fetal outcome 
increases with uric acid increase; estimation of serum uric acid 
can play a role in diagnosis and recognition of severity of PE 
allowing for safe delivery for mother and baby. 
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Khan, F., Rahman, M. M., 
Alam, K. S., & Das, S. R. 
(2011). Impairment of Renal 
Function in Eclampsia. 
Bangladesh Journal of 
Obstetrics & Gynaecology, 
26(1), 31–36. 
Cross-
sectional 
case-
control 
study 
Dhaka Medical College 
Hospital 
 
July 2009—December 
2009 
 
50 diagnosed case of 
eclampsia 
50 normal pregnancies 
3894 non-eclamptic patients and 
403 eclamptic patients were 
admitted during the period, 50 cases 
were randomly selected and 50 parity 
and age-matched control selected. 
Medical history, clinical information 
and other laboratory tests were 
collected/performed for each 
participant. 
 
• 30% of cases had impaired renal function, compared to the 
overall rate, at the Hospital, of 10% 
• Multigravida patients with eclampsia were more likely to 
experience impaired renal function vs. primigravida patients 
• Eclamptic patients who experienced impaired renal function had 
significantly higher BP and lower platelet counts compared to 
eclampsia patients with normal kidney function 
• Renal function impairment is common among patients with 
eclampsia 
Khatun, A., Latifa, S., Shahla, 
K., Anowara, B., Suhrab, A., 
Rashid, H. U., & Ullah, S. 
(2003). Assessment of renal 
insufficiency in gestational 
proteinuric hypertension in 
third trimester pregnancy. 
Bangladesh Medical 
Research Council Bulletin, 
29(3), 103–112. 
Prospecti
ve case 
control 
study 
Bangabandhu Sheikh 
Mujib Medical University 
 
August 1997-September 
1998 
 
50 cases of pregnancy-
induced proteinuric 
hypertension 
 
54 cases were non-
proteinuric normotensive 
controls 
Inclusion criteria for cases were: 
primigravid, 32-41 weeks gestation, 
hypertensive pregnant women with or 
without oedema 
 
Exclusion criteria were: known 
essential hypertension, known 
chronic renal disease/chronic 
hypertension, multiple pregnancy, 
and pregnancy with diabetes mellitus 
 
BP measurement, 10 ml venous 
blood sample and 24 hr urine 
collection were conducted on all 
participants. BP was measured twice, 
six hours apart with 24 hours.  
 
Serum creatinine and blood urea 
were analyzed.  
• Gestational Proteinuric Hypertension (GPH) “hypertension 
BP>140/90 mmHg or higher on two occasions & proteinuria 
>3gm/2hour [sic], oedema and some times [sic] coagulation and 
liver function abnormalities, renal function abnormalities or both 
occurs primarily in nulliparous usually after 20th gestational 
week.” 
• The study found a significant difference in urinary protein mean 
between the proteinuric hypertensive cases (335.2+ 74.14) 
compared to the non-proteinuric normotensive controls 
(133.24+29.83) 
• Differences in clinical characteristics between groups included: 
46.29% of cases and 0% of controls experienced headache, 
• 55% of cases <37 weeks had premature babies, (compared to 
16.66% in the normotensive group <37weeks 
• Study found slight decline in renal function  
Kishwara S, Tanira S, Omar E, 
Wazed F, Ara S. Effects of 
Preeclampsia on Perinatal 
Outcome - A study done in the 
specialized urban hospital set 
up in Bangladesh. 
Bangladesh J Med Sci. 
2011;40(1):33–6. 
Prospecti
ve case 
control 
study 
Dhaka Medical College 
Hospital and Mitford 
Hospital, Dhaka 
 
August 2005-June 2006 
 
60 pregnant women 
(Group A: 30 normal 
pregnancies; Group B: 30 
cases of preeclampsia) 
Maternal and fetal outcomes of all 
participants were observed and 
recorded and analyzed.  
 
Perinatal outcome data were 
collected from delivery notes. 
 
Exclusion criteria were: chronic 
hypertension, eclampsia, pregnancy 
induced hypertension, placenta 
praevia antepartum haemorrhage, 
diabetes mellitus, Rh-negative 
mother, VDRL-positive mother, and 
gestational age <35 weeks and >40 
weeks. 
• Preeclampsia is “characterized by an elevation in blood 
pressure, proteinuria and by a reduction in plasma volume, an 
increase in peripheral resistance and a generalized 
vasoconstriction. It usually develops after 20 weeks of gestation 
and resolves after delivery of placenta.” 
• Group A characteristics: 38.27 + 1.26 weeks gestation, 46.7% 
were primiparous. 
• Group B (PE) characteristics: 36.90 + 1.03 weeks gestation, 
63.3% were primiparous. 
• Mean difference in gestational age was statistically different 
between the two groups. 
• Mean birthweight for neonates was significantly lower in Group B 
(2.26+0.41kg) and Group A (2.800+0.27 kg) 
Nahar K, Yesmin S, Hossain I, 
Yasmin H, Nahar L, 
Shamsuddin L. Ocular 
Changes in Eclampsia 
Patients Among 100 Cases in 
Mymensingh Medical College 
Hospital, Bangladesh. CBMJ 
[Internet]. 2012 Oct;1(2):19–
25. 
cross 
sectional 
case 
control 
study 
Mymensingh Medical 
College Hospital 
 
March 2008-February 
2009. 
 
100 cases of eclampsia  
And 
100 controls; 
normotensive pregnancies 
“Visual aquity[sic]” was recorded and 
“fundoscopic” examinations were 
performed by an ophthalmologist 
within 24 hours of admission for all 
study participants. 
Follow up exams were performed 
seven days later for any patients with 
abnormalities after first exam.  
 
Data were recorded and analyzed.  
• During the study, incidence of eclampsia was: 7.5% (566 cases/ 
7542 deliveries) 
• Seizures usually occur in the second half of pregnancy and up to 
nine days post delivery but can occur up to six weeks after 
delivery. 
• Systolic BP among cases: 38% >160 mmHg, 41% 140-160 
mmHg, and 22% <140 *(Note: this = 101%) 
• Diastolic BP among cases: 36% >110 mmHg, 48% 90-110 
mmHg, 6% <90 *(Note: this = 90%) 
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• Incidence of “ocular involvement” among cases = 44% and 
among controls = 8% 
• Ocular changes included: abnormal visual acuity, conjunctival 
changes, disk changes, vascular changes and retinal changes 
•  
Nessa SST, Polash MMI, 
Islam M, Anam AM, Bhuiyan 
MMR. HELLP syndrome : An 
experience of treating with 
plasma exchange. 
Bangladesh Crit Care J. 
2013;1(2):102–3. 
Case 
Report 
Square Hospital Limited, 
Dhaka 
 
1 Case HELLP Syndrome 
32 year-old woman 38 weeks 
pregnant was admitted to the ICU 
with severe PE, manifesting with 
epigastric pain, 160/120 mmHG BP, 
and proteinuria. She was delivered by 
caesarian section due to severe PE 
and fetal distress.  
• HELLP syndrome diagnosis requires: “Microangiopathic 
hemolytic anemia with characteristic schistocytes (also called 
helmet cells) on blood smear. Other signs suggestive of 
hemolysis include an elevated LDH or indirect bilirubin and a low 
serum haptoglobin concentration (< 25 mg/dL). Platelet cound < 
100,000 cells/microL, Serum LDH >600 IU/L or total bilirubin > 
1.2 mg/dL. Serum AST >70 IU/L. Some investigators obtain ALT 
levels instead of, or in addition to, AST levels. An advantage of 
the AST is that it is a single test that reflects both hepatocellular 
necrosis and red cell hemolysis.” 
• Lesser known criteria: Mississipi Criteria which “divides patients 
into three groups based on lowest observed perinatal platelet 
count. (1: <50,000cmm, 2: >50,000-100,000 /cmm and 3: 
>100,000-150,000 /cmm.”  
• After c/s, her BP remained high and she was given IV 
antihypertensives and ultimately (due to blood counts, 
schistocytes, ALT and LDH levels she was ultimately diagnosed 
with HELLP syndrome and therapeutic plasma exchange (TPE) 
was performed over four sessions after which she was monitored 
at the hospital and released after 15 days total.  
Parna FH, Latif T, Sultana N, 
Ali MA, Chowdhury SB. 
Maternal & fetal outcome of 
eclamptic patients admitted 
in obstetrics & gynaecology 
department of secondary care 
hospital in Bangladesh. 
Mymensingh Med J. 
Bangladesh; 2013 
Jul;22(3):522–6. 
Cross 
sectional, 
observati
onal study 
General Hospital Tangail 
 
January 2008-December 
2008 
 
100 cases of eclampsia 
100 cases were randomly included 
from 124 cases of eclampsia. 
Diagnosis was made based on 
history, clinical presentation and 
bedside urine albumin tests. Relevant 
demographic information was 
recorded for all participants including 
number of convulsions prior to 
hospitalization and delivery, level of 
consciousness and mode of delivery.  
• 124 cases of eclampsia total at hospital out of 4727 patients; 
incidence of eclampsia = 2.62% 
• Of the participants (n=100), 80%<25 years old and 62% were 
primigravidae 
• 75% were diagnosed in antepartum period, 7% were intrapartum 
and 18% were postpartum 
• 52% were of gestational age >37 weeks and 44% were between 
28-37 weeks and 4% <28 weeks. 
• 51% had no ANC, 40% had infrequent ANC, only 9% had regular 
ANC 
• At admission, 20% had severe proteinuria, 64% had mild-
moderate proteinuria, and 16% did not have proteinuria at 
admission, but it developed later 
• 38% had <4 convulsions prior to admission, 49% had 5-10 
convulsions prior to admission and 13% experienced >10 
convulsions 
• Complications observed were: pulmonary edema (n=10), PPH 
(n=7), CVA (n=4), HELLP syndrome (n=3), obstetric shock (n=3), 
DIC (n=2), acute renal failure (n=1) 
Rahman MA, Rahman MH, 
Habib MH, Selimuzzaman 
SM. Placental changes in 
eclampsia and fetal outcome. 
Mymensingh Med J. 
Case 
control 
study 
Dhaka Medical College 
Hospital (DMCH) 
 
October 2000-August 
2001 
Placentas were collected after 
caesarian section delivery and 5cm of 
the umbilical cord was left attached 
to the placentas. Placentas were 
examined, cleaned, labeled and fixed 
• Neonatal weight was significantly lower in the eclampsia group 
(1.94 + 0.24 kg) compared to the control group (3.26 + 0.39 kg). 
• The eclampsia placentas had significantly lower weight, volume 
and diameter compared to control group.  
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Bangladesh; 2007 
Jul;16(2):191–6. 
 
40 placentas: 20 healthy 
and 20 with eclampsia. 
in 10% formal saline, weight, volume, 
and diameter were recoded. 
Information collected from patients 
included: birthweight, sex of neonate.  
 
Tissue sections from each placenta 
were taken and made into slides and 
examined microscopically.  
• The researchers observed a general tendency for increased 
intimal thickness in the branching sites for the eclampsia 
placentas. 
• This study concludes that the normal physiological progress of 
the placenta is complicated by metabolic disorders, like 
eclampsia.  
Rahman S, Gupta R Das, 
Islam N, Das A, Shaha AK, 
Khan MAI, et al. Pregnancy 
related acute renal failure in 
a tertiary care hospital in 
Bangladesh. J Med [Internet]. 
2012;13(2):129–32. 
Prospecti
ve 
observati
onal study 
Dhaka Medical College 
 
2007-2008 
 
57 women with pregnancy 
related acute renal failure 
(PRARF) 
Patients presenting with acute renal 
failure at department of Nephrology 
who did not have chronic kidney 
disease or pre-existing renal disease 
were recruited after informed consent 
was given.  
Detailed history was taken from all 
participants and examination and lab 
investigations were conducted for all 
participants.  
Urine examination, blood urea, serum 
creatinine, ultrasonography, complete 
blood count and liver function tests 
were routinely performed and 
recorded. 
 
• “Preeclampsia was diagnosed if hypertension and proteinuria 
occurred after 20 weeks of gestation, progressing to eclampsia 
when seizures occurred.” 
• Eclampsia was found to cause 19% of acute renal failure in 
participants.  
Saha L, Chowdhury SB. Study 
on primary cesarean section. 
Mymensingh Med J. 
Bangladesh; 2011 
Apr;20(2):292–7. 
Cross 
sectional 
Bangabanhu Sheikh Mujib 
medical University 
 
January 2004-December 
2004 
 
100 pregnant women 
awaiting cesarean section 
Women were recruited upon 
admission and observed until 
delivery. Complete medical history 
was taken, examinations performed 
and indication of cesarean section 
(CS) as well as any complications 
were recorded and data were 
compiled and analyzed 
• 1275 women were admitted to the obstetric department of 
BSMMU during the study period. 760 needed cesarean section. 
565 underwent primary CS. 
• 100 participants were randomly selected 
• Most common indication for CS was fetal distress; second most 
common indication for CS was pre-eclampsia (14%, n=14 cases).  
• 10 of the cases of PE were primigravidae. 
Saha M, Khan J. Maternal & 
Fetal Outcome of 
Hypertensive Disorders of 
Pregnancy-A Study of 100 
Cases, In FMCH, Faridpur. J 
Dhaka Med Coll. 
2011;20(2):183–7. 
Prospecti
ve cross 
sectional 
study 
Faridpur Medical College 
Hospital 
 
October 2005-September 
2006 
 
100 cases of HDP 
Patients were diagnosed based on 
clinical presentation and laboratory 
tests of albumin, serum uric acid 
levels and USG. Patients and fetuses 
were monitored and BP checked 
every 6 hours. 
• During the study period, there were 230 cases of HDP out of 
2786 patients making the incidence of HDP = 8.25% 
• Among 100 cases, 72% were eclampsia (60 cases antepartum, 
3 intrapartum, 9 postpartum), 12% gestational hypertension, 
13% gestational proteinuric hypertension.  
• Other complications included: pulmonary oedema (n=11), CVA 
(n=7), haematuria (n=6), ARF (n=4) and DIC (n=1) 
• 45 patients delivered by cesarean (LUCS) and 48 delivered 
vaginally and 2 were vacuum extraction. 
• 95 babies were delivered, 27 were healthy, 25 were premature, 
14 early neonatal deaths, 7 IUGR, 15 stillborn, and 7 intrauterine 
deaths. 
Sultana S, Hossain GA, 
Rahman H, Hasan N, Mannan 
S, Zannat S. Gross 
morphometry of human 
placenta in eclampsia. 
Mymensingh Med J. 
Bangladesh; 2006 
Jan;15(1):10–4. 
Case 
control 
Mymensingh Medical 
College 
 
January 2004-December 
2004 
 
20 normal placentas from 
term pregnancies 
 
Placentas were collected just after 
abdominal delivery through 
Caesarean section and the umbilical 
cord was cut leaving 5cm remaining 
attached to the placenta.  
 
Placentas were then prepared for 
analysis and weighed, volume 
calculated and  
• Eclampsia = “patients in whom the systolic and diastolic blood 
pressure had risen markedly above the normal level, together 
with proteinuria and decreased urine output associated with 
generalized edema and convulsion.” 
• Maternal age was differed significantly between control group 
(mean age: 26.45+4.43 years) and eclampsia group (23.44 + 
5.20 years);  
• Gestational age and neonatal weight were significantly lower in 
the eclamptic group as well 
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Citation Study 
Design 
Location/ dates/ sample 
size-study population 
Methods Main Findings/ limitations/conclusions 
25 placentas from women 
who had eclampsia 
• Placenta weight and volume were significantly lower among 
eclampsia placentas when compared to normal placentas 
• Eclampsia placentas mean volume = 326.400 + 66.95 ml and 
normal placenta mean volume = 532.500 +57.663 ml  
• This study supports the hypothesis that eclampsia is associated 
with intrauterine growth retardation which is related to 
alterations in uteroplacental blood flow  
Sultana S, Hossain GA, 
Rahman MH, Hasan N, 
Sultana SZ, Khalil M. 
Changes of placental 
diameter thickness and 
cotyledon in eclampsia. 
Mymensingh Med J. 
Bangladesh; 2007 
Jul;16(2):127–31. 
Case 
control 
Mymensingh Medical 
College 
 
January 2004-December 
2004 
 
20 normal placentas from 
term pregnancies 
 
25 placentas from women 
who had eclampsia 
Placentas were collected just after 
abdominal delivery through 
Caesarean section and the umbilical 
cord was cut leaving 5cm remaining 
attached to the placenta.  
 
Placentas were then prepared for 
analysis and diameter measured 
twice at right angles; the mean of the 
two measurements was recorded as 
the placental diameter. 
 
Placental thickness was measured 
with a long needle at five points. 
• Cotyledon numbers were significantly less in placentas with 
eclampsia (mean 14.24 + 1.665) compared to normal placentas 
(mean 17.200 +2.930 
• Placental diameter was significantly smaller in eclampsia 
placentas (15.500 +1.791 cm) compared to normal placentas 
(18.155 +2.074 cm) 
• No significant difference in placental thickness. 
• The study concluded that “the alterations in uteroplacental blood 
flow in eclampsia is responsible for changes in placental 
structure and function.” 
Tahmina H, Shahid A, Hosna 
A, Alam A. STUDY ON 
OUTCOME OF ECLAMPSIA 
PATIENTS IN DISTRICT 
HOSPITAL IN BANGLADESH. J 
Dhaka Med Coll. 
2014;23(2):223–6. 
Hospital 
based 
prospecti
ve study 
Sadar Hospital, Chuadanga 
 
January 2007-December 
2009 
 
50 cases of eclampsia 
Patients admitted with eclampsia or 
had developed convulsions after 
admission and delivery. 
 
 
• 7 were admitted with PE or PIH and developed eclampsia later 
• 10% of participants were delivered by assisted vaginal 
delivery and 10% by cesarean section (CS).  
• 41 (82%) were antepartum, 5(10%) were intrapartum and 4 (8%) 
were postpartum 
• 3 women died (due to multiorgan failure) 
•  
Uddin A, Nessa S, Chowdhury 
S, Banu M. Hypertensive 
Disorders of Pregnancy and 
It’S Outcome in a Tertiary 
Care Hospital. JAFMC 
Bangladesh. 2013;9(2):38–
42. 
Cross 
sectional 
study 
Institute of Child and 
Mother Health, Dhaka 
 
1 November 2010-30 
January 2011 
 
 
 
Pregnant women 17-35 years old who 
were diagnosed with HDP were 
selected randomly after admission 
and were interviewed with a 
structured questionnaire that had 
been pre-tested. 
• 79.4% had “pre eclamptic toxaemia” , 14.3% had eclampsia and 
6.3% had gestational hypertension 
• 50.8% were of single parity, 61.9% had no ANC, and 50.8% were 
delivered by CS.  
• 33.3% had IUGR, 44.4% were low birth weight (<2.2kg),  
Wazed F, Jahan S, Tanira S. 
INDICATION OF CAESAREAN 
SECTION OPERATION IN 
PRETERM PREGNANCY AND 
ITS OUTCOME – A STUDY OF 
100 CASES. J Dhaka Med 
Coll. 2009;18(2):124–6. 
Prospecti
ve study 
Dhaka Medical College 
Hospital and Mitford 
Hospital, Dhaka 
 
September 2002-August 
2003 
 
100 cases of preterm 
pregnancy 
Detailed history was taken upon 
admission and medical exam was 
performed. Data was analyzed and 
compared.  
• The two most common indications for caesarean section were 
eclampsia (24%) and preeclampsia (20%) 
 
  
60 
Annex V:  
PAPERS REMOVED DURING PHASE TWO AND EXCLUSION REASON 
Citation Exclusion Reason 
Adhikary, S., Tanira, S., Sultana, A., Wazed, F., & Sb, C. (2013). Maternal outcome in premature rupture of membrane - a study done in the tertiary level specialized hospital in 
Bangladesh. J Dhaka Med Coll., 22(1), 26–29 
Not PE/E 
Ahmed, S. (2014). Challenges of achieving and tracking MDG 5. The Lancet, 384, 1329–1331. http://doi.org/http://dx.doi.org/10.1016/S0140-6736(14)61096-5 Not PE/E 
Ameh, C., & Broek, N. van den. (2015). Making It Happen: Training health-care providers in emergency obstetric and newborn care. Best Practice & Research Clinical Obstetrics 
& Gynaecology, 29, 1077–1091. 
Not Bangladesh Specific 
Brown, E. A., Ruvolo, M., & Sabeti, P. C. (2013). Many ways to die, one way to arrive: how selection acts through pregnancy. Trends in Genetics, 29(10), 585–592. Not Bangladesh 
Dangat, K., Kilari, A., Mehendale, S., Lalwani, S., & Joshi, S. (2014). Preeclampsia alters milk neurotrophins and long chain polyunsaturated fatty acids. International Journal of 
Developmental Neuroscience, 33(0), 115–121. 
Not Bangladesh 
Hlimi, T. (2015). Association of anemia, pre-eclampsia and eclampsia with seasonality: A realist systematic review. Health & Place, 31(0), 180–192. Not Bangladesh 
Iyengar, K., Yadav, R., & Sen, S. (2012). Consequences of maternal complications in women’s lives in the first postpartum year: A prospective cohort study. Journal of Health, 
Population and Nutrition, 30(2), 226–240. 
Not Bangladesh 
Jahan, M., Hasanuzzaman, M., Mahbuba, S., Leena, K., Ahsan, G. U., Kuehl, T. J., … Uddin, M. N. (2015). P52. Prevalence of preeclampsia in patients of pre-gestational diabetic 
pregnancy in Bangladesh. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, 5(3), 250. 
No full text; published abstract 
Jowett, M. (2000). Safe motherhood interventions in low-income countries: an economic justification and evidence of cost effectiveness. Health Policy, 53(3), 201–228. Not Bangladesh 
Khosrowbeygi A, Ahmadvand H. Leptin to adiponectin ratio in preeclampsia. Bangladesh Med Res Counc Bull. Bangladesh; 2013 Apr;39(1):18–21. Not Bangladesh  
Kwok RK. A review and rationale for studying the cardiovascular effects of drinking water arsenic in women of reproductive age. Toxicol Appl Pharmacol [Internet]. 2007 Aug 1 
[cited 2015 Jun 4];222(3):344–50. 
Not specific enough information 
on PE/E and Bangladesh 
McCord C. A cost effective small hospital in Bangladesh: what it can mean for emergency obstetric care. Int J Gynecol Obstet [Internet]. 2003 Apr [cited 2015 Jun 4];81(1):83–
92. 
Not focused on PE/E 
McDonald S, Lutsiv O, Dzaja N, Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J 
Gynecol Obstet [Internet]. 2012 [cited 2015 Apr 30];118:90–6. 
Data relating to PE/E and 
Bangladesh from article in this 
review (Begum et al. 2000). 
Nahar K, Yasmin H. Near Miss Cases in Women of Bangladesh. Community Based Med J [Internet]. 2013;(01):63–5. Maternal complications in 
general 
Nahar K, Laila T, Akhter N, Shamsunnahar P, Khatun K, Chowdhury S. Management of hypertensive disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2010;25(1):24–
32. 
Not Bangladesh 
Nahar K. Indications of Caesarean Section - Study of 100 cases in Mymensingh Medical College Hospital . J Shaheed Suhrawardy Med Coll. 2009;1(1):6–10. Not focused on PE/E 
Nazeen R, Begum R, Sultana K. Rising Trend of Caesarean Section in a Tertiary Hospital Over a Decade. Jounal Bangladesh Coll Physicians Surg. 2011;29(3):126–32. Not focused on PE/E 
Nessa K, Saleh A Bin. Study of Some Sociodemographic Factors in Teenage Pregnancy. Chattagram Maa-O-Shishu Hosp Med Coll J. 2014;13(3):21–5. Risk factors for Teenage 
Pregnancy is main focus 
 61 
 
Citation Exclusion Reason 
Norton ME. Maternal Mortality in Bangladesh: A Countdown to 2015 Country Case Study EDITORIAL COMMENT. Obstet Gynecol Surv. 2015 Feb;70(2):74–5. No Full Text Available  
Pal A, Bhattacharyya R, Adhikari S, Roy A, Chakrabarty D, Ghosh P, et al. Eclampsia-scenario in a hospital--a ten years study. Bangladesh Med Res Counc Bull [Internet]. 
2011;37(2):66–70. 
Not Bangladesh 
Rahman A, Islam R, Habib R, Bhowmik NB, Haque A. Headache in pregnancy: Recent insight . Bangladesh Crit Care J. 2013;1(2):93–8. Not specific to Bangladesh 
Rahman Z, Helali AM. Facts about Magnesium Sulfate : Time to Revise the Safety Concern in Obstetric Use. J Enam Med Coll. 2014;4(3):177–83. Not Bangladesh 
Shand A, Nassar N, von Dadelszen P, Innis S, Green T. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 
An Int J Obstet Gynaecol. 2010;117(1593-1598):160. 
Not Bangladesh 
Sharifun N, Syeda A, Zakia N. RISK FACTORS ANALYSIS IN ASPHYXIATED NEWBORN AND THEIR NEUROLOGICAL OUTCOME IN RELATION TO HYPOXIC-ISCHAEMIC 
ENCEPHALOPATHY. J Paediatr Surg Bangladesh. 2013;4(2):54–7. 
Not focused on PE/E impact 
newborn health outcomes 
Sharmeen M, Shamsunnahar PA, Laita TR, Chowdhury SB. Overt and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome. 
Bangladesh Med Res Counc Bull [Internet]. 2014;40(2):52–7. 
Not focused on PE/E 
Shirin S, Nahar S. Maternal Mortality - A public health problem. Ibrahim Med Coll J. 2012;6(2):64–9. Not specific enough information 
on PE/E and Bangladesh 
Sikder SS, Labrique AB, Shamim AA, Ali H, Mehra S, Wu L, et al. Risk factors for reported obstetric complications and near misses in rural northwest Bangladesh: analysis from 
a prospective cohort study. BMC Pregnancy Childbirth. 2014 Oct;14. 
Not focused on PE/E 
Sikder SS, Labrique AB, Ali H, Hanif AAM, Klemm RDW, Mehra S, et al. Availability of emergency obstetric care (EmOC) among public and private health facilities in rural northwest 
Bangladesh. BMC Public Health. 2015 Jan;15. 
Not PE/E 
Sultana S, Begum A, Khan M. Disseminated Intravascular Coagulation ( Dic ) in Obstetric Practice. J Dhak. 2011;20(1):68–74. Not focused on PE/E 
Sultana N, Huq SR, Parvin T, Hussain MA, Rahaman A. Outcome of Teenage Pregnancy Associated with Medical Conditions. J Shaheed Suhrawardy Med Coll. 2009;1(2):10–3 Not focused on PE/E 
Talukder M, Islam I, Begum S, Kundu G, Rahman S. Posterior reversible encephalopathy syndrome - An underrecognized manifestation of systemic lupus erythematosus. J 
Rheumatol [Internet]. 2006;33(11):2178–83. 
Not PE/E 
The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled 
trial. Lancet [Internet]. 2002 [cited 2015 Apr 30]; Available from: http://www.sciencedirect.com/science/article/pii/S0140673602087780 
Not specific enough information 
on Bangladesh 
Ullah MA, Barman A, Siddique MA, Haque AKME. Prevalence of asymptomatic bacteriuria and its consequences in pregnancy in a rural community of Bangladesh. Bangladesh 
Med Res Counc Bull. Bangladesh; 2007 Aug;33(2):60–4. 
Not PE/E 
von Dadelszen P, Ansermino JM, Dumont G, Hofmeyr GJ, Magee LA, Mathai M, et al. Improving maternal and perinatal outcomes in the hypertensive disorders of pregnancy: a 
vision of a community-focused approach. Int J Gynaecol Obstet [Internet]. 2012 Oct [cited 2015 Jun 4];119 Suppl:S30–4. 
Not Bangladesh 
West KP, Shamim AA, Mehra S, Labrique AB, Ali H, Shaikh S, et al. Effect of maternal multiple micronutrient vs iron-folic acid supplementation on infant mortality and adverse 
birth outcomes in rural Bangladesh: the JiVitA-3 randomized trial. J Am Med Assoc [Internet]. 2014;312(24):2649–58. 
Not PE/E 
 
